UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549

FORM 10-Q

 
x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
 
For the quarterly period ended September 30, 2014
 
OR
 
¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
 
For the transition period from              to             
 
Commission file number 001-12019

 
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)

 

 

Pennsylvania	 	23-0993790	
(State or other jurisdiction of
incorporation or organization)	 	(I.R.S. Employer
Identification No.)	

One Quaker Park, 901 E. Hector Street,
Conshohocken, Pennsylvania	 	19428 – 2380	
(Address of principal executive offices)	 	(Zip Code)	
 
Registrant’s telephone number, including area code: 610-832-4000
 
Not Applicable
Former name, former address and former fiscal year, if changed since last report.

 
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   x      No   ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   x      No   ¨
 
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 	Large accelerated filer   x     	 	Accelerated filer  ¨	 	
 	Non-accelerated filer  ¨ (Do not check if smaller reporting company)	Smaller reporting company  ¨	 	
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes   ¨     No   x
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Number of Shares of Common Stock
Outstanding on September 30, 2014	 	 
13,269,266	

 

 

QUAKER CHEMICAL CORPORATION AND CONSOLIDATED SUBSIDIARIES

 	  	 	Page	
PART I.	  	FINANCIAL INFORMATION	 	
Item 1.	  	Financial Statements (unaudited)	 	
 	 	Condensed Consolidated Statement of Income for the Three and Nine Months Ended September 30, 2014 and September 30, 2013	3	
 	  	Condensed Consolidated Statement of Comprehensive Income for the Three and Nine Months Ended September 30, 2014 and September 30, 2013	4	
 	  	Condensed Consolidated Balance Sheet at September 30, 2014 and December 31, 2013	5	
 	  	Condensed Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2014 and September 30, 2013	6	
 	  	Notes to Condensed Consolidated Financial Statements	7	
Item 2.	  	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22	
Item 3.	  	Quantitative and Qualitative Disclosures about Market Risk	30	
Item 4.	  	Controls and Procedures	31	
PART II.	  	OTHER INFORMATION	32	
Item 1.	 	Legal Proceedings	32	
Item 2.	 	Unregistered Sales of Equity Securities and Use of Proceeds	32	
Item 6.	  	Exhibits	33	
Signatures	33	

2

 Table of Contents

PART I
FINANCIAL INFORMATION
 
Item 1.                                Financial Statements (Unaudited).

 
Quaker Chemical Corporation
 
Condensed Consolidated Statement of Income
(Dollars in thousands, except per share data)
 
 	 	Unaudited	
 	 	Three Months Ended September 30,	 	 	Nine Months Ended September 30,	
 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	
Net sales	 	$	198,867 	 	 	$	184,059 	 	 	$	571,827 	 	 	$	545,098 	
Cost of goods sold	 	 	128,567 	 	 	 	118,069 	 	 	 	368,197 	 	 	 	349,186 	
Gross profit	 	 	70,300 	 	 	 	65,990 	 	 	 	203,630 	 	 	 	195,912 	
Selling, general and administrative expenses	 	 	49,747 	 	 	 	47,183 	 	 	 	142,759 	 	 	 	139,901 	
Operating income	 	 	20,553 	 	 	 	18,807 	 	 	 	60,871 	 	 	 	56,011 	
Other income (expense), net	 	 	914 	 	 	 	(685)	 	 	 	558 	 	 	 	1,962 	
Interest expense	 	 	  (641)	 	 	 	(717)	 	 	 	(1,747)	 	 	 	(2,223)	
Interest income	 	 	642 	 	 	 	267 	 	 	 	1,990 	 	 	 	665 	
Income before taxes and equity in net income of associated companies	 	 	21,468 	 	 	 	17,672 	 	 	 	61,672 	 	 	 	56,415 	
Taxes on income before equity in net income of associated companies	 	 	5,724 	 	 	 	5,972 	 	 	 	18,808 	 	 	 	16,933 	
Income before equity in net income of associated companies	 	 	15,744 	 	 	 	11,700 	 	 	 	42,864 	 	 	 	39,482 	
Equity in net income of associated companies	 	 	375 	 	 	 	1,605 	 	 	 	2,506 	 	 	 	4,689 	
Net income	 	 	16,119 	 	 	 	13,305 	 	 	 	45,370 	 	 	 	44,171 	
Less: Net income attributable to noncontrolling interest	 	 	423 	 	 	 	754 	 	 	 	1,517 	 	 	 	1,918 	
Net income attributable to Quaker Chemical Corporation	 	$	15,696 	 	 	$	12,551 	 	 	$	43,853 	 	 	$	42,253 	
Per share data:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income attributable to Quaker Chemical Corporation Common	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Shareholders – basic	 	$	1.18 	 	 	$	0.95 	 	 	$	3.31 	 	 	$	3.21 	
Net income attributable to Quaker Chemical Corporation Common	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Shareholders – diluted	 	$	1.18 	 	 	$	0.95 	 	 	$	3.31 	 	 	$	3.21 	
Dividends declared	 	$	0.300 	 	 	$	0.250 	 	 	$	0.850 	 	 	$	0.745 	

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

 Table of Contents

Quaker Chemical Corporation
 
Condensed Consolidated Statement of Comprehensive Income
(Dollars in thousands)

 

 	 	Unaudited	 	 	
 	 	Three Months Ended	 	 	Nine Months Ended	 	 	
 	 	September 30,	 	 	September 30,	 	 	
 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	 	 	
Net income	 	$	16,119 	 	 	$	13,305 	 	 	$	45,370 	 	 	$	44,171 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Other comprehensive (loss) income, net of tax	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Currency translation adjustments	 	 	(11,655)	 	 	 	2,272 	 	 	 	(9,400)	 	 	 	(3,674)	 	 	
Defined benefit retirement plans	 	 	1,797 	 	 	 	(180)	 	 	 	2,956 	 	 	 	1,688 	 	 	
Unrealized loss on available-for-sale securities	 	 	(214)	 	 	 	(333)	 	 	 	(316)	 	 	 	(616)	 	 	
Other comprehensive (loss) income	 	 	(10,072)	 	 	 	1,759 	 	 	 	(6,760)	 	 	 	(2,602)	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Comprehensive income	 	 	6,047 	 	 	 	15,064 	 	 	 	38,610 	 	 	 	41,569 	 	 	
Less: comprehensive income attributable to noncontrolling interest	 	 	(177)	 	 	 	(499)	 	 	 	(1,470)	 	 	 	(699)	 	 	
Comprehensive income attributable to Quaker Chemical Corporation	 	$	5,870 	 	 	$	14,565 	 	 	$	37,140 	 	 	$	40,870 	 	 	
 
The accompanying notes are an integral part of these condensed consolidated financial statements.

4

 Table of Contents

Quaker Chemical Corporation
 
Condensed Consolidated Balance Sheet
(Dollars in thousands, except par value and share amounts)

 	 	Unaudited	 	 	
 	 	September 30, 2014	 	 	December 31, 2013	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	
ASSETS	 	 	 	 	 	 	 	 	 	 	
Current assets	 	 	 	 	 	 	 	 	 	 	
        Cash and cash equivalents	 	$	64,221 	 	 	$	68,492 	 	 	 	
        Accounts receivable, net	 	 	188,982 	 	 	 	165,629 	 	 	 	
        Inventories	 	 	 	 	 	 	 	 	 	 	
                Raw materials and supplies	 	 	40,348 	 	 	 	37,063 	 	 	 	
                Work-in-process and finished goods	 	 	40,186 	 	 	 	34,494 	 	 	 	
        Prepaid expenses and other current assets	 	 	19,818 	 	 	 	23,169 	 	 	 	
                Total current assets	 	 	353,555 	 	 	 	328,847 	 	 	 	
Property, plant and equipment, at cost	 	 	233,371 	 	 	 	233,865 	 	 	 	
        Less accumulated depreciation	 	 	(149,575)	 	 	 	(148,377)	 	 	 	
                Net property, plant and equipment	 	 	83,796 	 	 	 	85,488 	 	 	 	
Goodwill	 	 	70,053 	 	 	 	58,151 	 	 	 	
Other intangible assets, net	 	 	59,301 	 	 	 	31,272 	 	 	 	
Investments in associated companies	 	 	21,149 	 	 	 	19,397 	 	 	 	
Deferred income taxes	 	 	21,996 	 	 	 	24,724 	 	 	 	
Other assets	 	 	34,360 	 	 	 	36,267 	 	 	 	
                Total assets	 	$	644,210 	 	 	$	584,146 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	
LIABILITIES AND EQUITY	 	 	 	 	 	 	 	 	 	 	
Current liabilities	 	 	 	 	 	 	 	 	 	 	
        Short-term borrowings and current portion of long-term debt	 	$	571 	 	 	$	1,395 	 	 	 	
        Accounts and other payables	 	 	85,888 	 	 	 	75,580 	 	 	 	
        Accrued compensation	 	 	16,058 	 	 	 	20,801 	 	 	 	
        Other current liabilities	 	 	28,362 	 	 	 	33,080 	 	 	 	
               Total current liabilities	 	 	130,879 	 	 	 	130,856 	 	 	 	
Long-term debt	 	 	62,009 	 	 	 	17,321 	 	 	 	
Deferred income taxes	 	 	5,920 	 	 	 	6,729 	 	 	 	
Other non-current liabilities	 	 	78,391 	 	 	 	84,544 	 	 	 	
               Total liabilities	 	 	277,199 	 	 	 	239,450 	 	 	 	
Equity	 	 	 	 	 	 	 	 	 	 	
         Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding	 	 	 	 	 	 	 	 	 	 	
            2014 – 13,269,266 shares; 2013 – 13,196,140 shares	 	 	13,269 	 	 	 	13,196 	 	 	 	
         Capital in excess of par value	 	 	96,717 	 	 	 	99,038 	 	 	 	
         Retained earnings	 	 	290,876 	 	 	 	258,285 	 	 	 	
         Accumulated other comprehensive loss	 	 	(41,413)	 	 	 	(34,700)	 	 	 	
               Total Quaker shareholders’ equity	 	 	359,449 	 	 	 	335,819 	 	 	 	
Noncontrolling interest	 	 	7,562 	 	 	 	8,877 	 	 	 	
Total equity	 	 	367,011 	 	 	 	344,696 	 	 	 	
         Total liabilities and equity	 	$	644,210 	 	 	$	584,146 	 	 	 	

 
The accompanying notes are an integral part of these condensed consolidated financial statements.

5

 Table of Contents

Quaker Chemical Corporation
 
Condensed Consolidated Statement of Cash Flows
(Dollars in thousands)
 
 	 	Unaudited	
 	 	For the Nine Months Ended	
 	 	September 30,	
 	 	2014 	 	 	2013 	
Cash flows from operating activities	 	 	 	 	 	 	 	
Net income	 	$	45,370 	 	 	$	44,171 	
Adjustments to reconcile net income to net cash provided by operating activities:	 	 	 	 	 	 	 	
Depreciation	 	 	9,154 	 	 	 	9,219 	
Amortization	 	 	2,754 	 	 	 	2,621 	
Equity in undistributed earnings of associated companies, net of dividends	 	 	(2,306)	 	 	 	(2,525)	
Deferred compensation and other, net	 	 	1,672 	 	 	 	(50)	
Stock-based compensation	 	 	3,959 	 	 	 	3,133 	
(Gain) loss on disposal of property, plant and equipment	 	 	(125)	 	 	 	193 	
Insurance settlements realized	 	 	(1,214)	 	 	 	(731)	
Pension and other postretirement benefits	 	 	178 	 	 	 	(561)	
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:	 	 	 	 	 	 	 	
Accounts receivable	 	 	(23,061)	 	 	 	(13,222)	
Inventories	 	 	(9,143)	 	 	 	(4,569)	
Prepaid expenses and other current assets	 	 	1,332 	 	 	 	1,017 	
Accounts payable and accrued liabilities	 	 	9,470 	 	 	 	13,256 	
Net cash provided by operating activities	 	 	38,040 	 	 	 	51,952 	
 	 	 	 	 	 	 	 	
Cash flows from investing activities	 	 	 	 	 	 	 	
Investments in property, plant and equipment	 	 	(8,376)	 	 	 	(7,330)	
Payments related to acquisitions, net of cash acquired	 	 	(51,947)	 	 	 	(2,478)	
Proceeds from disposition of assets	 	 	178 	 	 	 	391 	
Interest earned on insurance settlements	 	 	34 	 	 	 	40 	
Change in restricted cash, net	 	 	1,180 	 	 	 	691 	
Net cash used in investing activities	 	 	(58,931)	 	 	 	(8,686)	
 	 	 	 	 	 	 	 	
Cash flows from financing activities	 	 	 	 	 	 	 	
Proceeds from long-term debt	 	 	45,000 	 	 	 	— 	
Repayment of long-term debt	 	 	(1,106)	 	 	 	(12,289)	
Dividends paid	 	 	(10,580)	 	 	 	(9,721)	
Stock options exercised, other	 	 	(194)	 	 	 	(510)	
Excess tax benefit related to stock option exercises	 	 	430 	 	 	 	815 	
Purchase of a noncontrolling interest in an affiliate	 	 	(7,422)	 	 	 	— 	
Payment of acquisition-related earnout liability	 	 	(4,709)	 	 	 	— 	
Distributions to noncontrolling affiliate shareholders	 	 	(1,806)	 	 	 	(30)	
Net cash provided by (used in) financing activities	 	 	19,613 	 	 	 	(21,735)	
Effect of exchange rate changes on cash	 	 	(2,993)	 	 	 	(133)	
Net (decrease) increase in cash and cash equivalents	 	 	(4,271)	 	 	 	21,398 	
Cash and cash equivalents at beginning of period	 	 	68,492 	 	 	 	32,547 	
Cash and cash equivalents at end of period	 	$	64,221 	 	 	$	53,945 	
 	 	 	 	 	 	 	 	
Supplemental cash flow disclosures:	 	 	 	 	 	 	 	
Non-cash activities:	 	 	 	 	 	 	 	
Accrued property, plant and equipment purchases	 	$	— 	 	 	$	1,178 	
 
The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands, except share and per share amounts)
(Unaudited)

Note 1 – Condensed Financial Information
 
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting and the United States Securities and Exchange Commission regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. During the first quarter of 2014, the Company revised its Consolidated Balance Sheet for December 31, 2013 with a $335 reduction to retained earnings and a corresponding increase to its long-term deferred tax liability, relating to an adjustment that would have occurred when the Company adopted the equity method of accounting for its interest in a captive insurance equity affiliate. Certain other reclassifications of prior year data have been made to improve comparability.  The results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2013.
 
Venezuela currently operates three local exchange markets to obtain U.S. Dollars:  the CADIVI, SICAD I and SICAD II.   Under generally accepted principles in the United States, Venezuela’s economy is considered to be hyper inflationary, so, accordingly, all gains and losses resulting from the remeasurement of the Company’s Venezuelan equity affiliate Kelko Quaker Chemical, S.A. (“Kelko”) to the CADIVI published exchange are required to be recorded directly to the Condensed Consolidated Statement of Income.   As of September 30, 2014, the Company has a $1,644 investment in Kelko, which is currently valued at the CADIVI exchange rate.  The Company currently does not have access to trade on the SICAD I exchange rate.  During the second quarter of 2014, the Company recorded a charge of $321, or $0.02 per diluted share, related to the conversion of certain Venezuelan Bolivar Fuerte to U.S. Dollars on the SICAD II exchange.  During the first quarter of 2013, the Venezuelan Government announced a devaluation of the Bolivar Fuerte, which resulted in a charge of $357, or $0.03 per diluted share.
 
During 2002 and 2003, the Company’s Netherlands and Italian subsidiaries paid excise taxes on mineral oil sales in Italy for a total amount of approximately $2,000.  Alleging that the mineral oil excise tax was contrary to European Union directives, the subsidiaries filed with the Customs’ Authority of Milan (“Customs Office” or “Office”) requests to obtain a refund of the above-mentioned amount.  The parties appealed rulings to various levels of tax courts up through the Supreme Court of Italy.  In March 2012, the Supreme Court rejected the appeal of the Customs Office, ruling in favor of the subsidiaries and granting a refund for the amounts requested.  After filing an enforcement action, the Company collected approximately $2,057, along with approximately $483 of interest, in the second quarter of 2013.  This amount was recorded as other income on the Company’s Condensed Consolidated Statement of Income in the second quarter of 2013.
 
As part of the Company’s chemical management services, certain third-party product sales to customers are managed by the Company. Where the Company acts as the principal, revenue is recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as an agent, such revenue is recorded using net reporting as service revenues, at the amount of the administrative fee earned by the Company for ordering the goods.  Third-party products transferred under arrangements resulting in net reporting totaled $11,829 and $33,328 for the three and nine months ended September 30, 2014, respectively. Third-party products transferred under arrangements resulting in net reporting totaled $10,950 and $30,288 for the three and nine months ended September 30, 2013, respectively.
 
Note 2 – Recently Issued Accounting Standards
 
The Financial Accounting Standards Board (“FASB”) issued an accounting standard in August 2014 to outline specific requirements for an entity to evaluate its ability to continue as a going concern.  The new guidance requires a company to assess whether certain conditions or events exist at the date financial statements are issued that may raise substantial doubt about its ability to continue as a going concern for the next year.  If a company concludes that it is not able to continue as a going concern and it is not able to mitigate the conditions and events that resulted in the entity’s ability to continue as a going concern, footnote disclosure is required.  The guidance is effective for the annual and interim periods beginning after December 15, 2016.  Early adoption is permitted.  The Company is currently evaluating the effects of this guidance, but does not expect a material impact.
 
The FASB issued an accounting standard update in May 2014 regarding the accounting for and disclosures of revenue recognition.  Specifically, the update outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers, which will be common to both GAAP and International Financial Reporting Standards (“IFRS”).  The model focuses on revenue recognition to reflect the actual consideration to which the entity expects to be entitled in exchange for the goods or services defined in the contract, including multiple performance obligations.  The guidance is effective for annual and interim periods beginning after December 15, 2016, which allows for full retrospective adoption of prior period data or a modified retrospective

7

Table of Contents
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

 
adoption whereby the cumulative past effects are recorded and disclosed in the current period.  Early adoption is not permitted.  Currently, the Company is evaluating the effect that the guidance may have on its financial statements.
 
Note 3 – Out-of-Period Adjustment
 
During 2012, the Company reassessed its ability to significantly influence the operating and financial policies of its captive insurance equity affiliate, Primex.  Based on its ownership percentage and other factors, the Company determined that, during 2012, the Company obtained the ability to significantly influence Primex and, as a result, changed its method of accounting from the cost to equity method.   During the first quarter of 2013, the Company identified errors in Primex’s estimated 2012 financial statements, which primarily related to a reinsurance contract held by Primex.  The identified errors resulted in a cumulative $1,038 understatement of the Company’s equity in net income from associated companies for the year ended December 31, 2012.  The Company corrected the errors related to Primex in the first quarter of 2013, which had the net effect of increasing equity in net income from associated companies by $1,038 for the three months ended March 31, 2013.  The Company did not believe this adjustment was material to its consolidated financial statements for the years ended December 31, 2012 or December 31, 2013 and, therefore, did not restate any prior period amounts.
 
Note 4 – Business Segments
 
The Company’s reportable operating segments are organized by geography as follows: (i) North America, (ii) Europe, Middle East and Africa (“EMEA”), (iii) Asia/Pacific and (iv) South America.  Operating earnings, excluding indirect operating expenses, for the Company’s reportable operating segments are comprised of revenues less costs of goods sold and SG&A directly related to the respective regions’ product sales.  The indirect operating expenses consist of SG&A related expenses that are not directly attributable to the product sales of each respective reportable operating segment.  Other items not specifically identified with the Company’s reportable operating segments include interest expense, interest income, license fees from non-consolidated affiliates and other income (expense).
 
The following table presents information about the Company’s reported segments for the three and nine months ended September 30, 2014 and September 30, 2013:

 	 	Three Months Ended	 	 	Nine Months Ended	
 	 	September 30,	 	 	September 30,	
 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	
Net sales	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
North America	 	$	87,909 	 	 	$	79,602 	 	 	$	247,137 	 	 	$	231,111 	
EMEA	 	 	49,352 	 	 	 	44,452 	 	 	 	148,769 	 	 	 	140,314 	
Asia/Pacific	 	 	49,601 	 	 	 	44,063 	 	 	 	136,661 	 	 	 	124,593 	
South America	 	 	12,005 	 	 	 	15,942 	 	 	 	39,260 	 	 	 	49,080 	
Total net sales	 	$	198,867 	 	 	$	184,059 	 	 	$	571,827 	 	 	$	545,098 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Operating earnings, excluding indirect operating expenses	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
North America	 	$	17,771 	 	 	$	15,203 	 	 	$	51,350 	 	 	$	46,238 	
EMEA	 	 	8,589 	 	 	 	6,781 	 	 	 	24,794 	 	 	 	22,332 	
Asia/Pacific	 	 	11,925 	 	 	 	11,214 	 	 	 	32,064 	 	 	 	31,612 	
South America	 	 	883 	 	 	 	2,598 	 	 	 	3,281 	 	 	 	7,830 	
Total operating earnings, excluding indirect operating expenses	 	 	39,168 	 	 	 	35,796 	 	 	 	111,489 	 	 	 	108,012 	
Indirect operating expenses	 	 	(17,489)	 	 	 	(16,131)	 	 	 	(47,864)	 	 	 	(49,380)	
Amortization expense	 	 	(1,126)	 	 	 	(858)	 	 	 	(2,754)	 	 	 	(2,621)	
Consolidated operating income	 	 	20,553 	 	 	 	18,807 	 	 	 	60,871 	 	 	 	56,011 	
Other income (expense), net	 	 	914 	 	 	 	(685)	 	 	 	558 	 	 	 	1,962 	
Interest expense	 	 	(641)	 	 	 	(717)	 	 	 	(1,747)	 	 	 	(2,223)	
Interest income	 	 	642 	 	 	 	267 	 	 	 	1,990 	 	 	 	665 	
Consolidated income before taxes and equity in net income of associated companies	 	$	21,468 	 	 	$	17,672 	 	 	$	61,672 	 	 	$	56,415 	
 
Inter-segment revenue for the three and nine months ended September 30, 2014 was $2,605 and $6,411 for North America, $5,801 and $16,582 for EMEA, $127 and $329 for Asia/Pacific and zero for South America, respectively.  Inter-segment revenue for the three and nine months ended September 30, 2013 was $2,486 and $7,333 for North America, $5,771 and $15,427 for EMEA, $58 and $363 for Asia/Pacific and zero for South America, respectively.  However, all inter-segment transactions have been eliminated from each reportable operating segment’s net sales and earnings for all periods presented above.

8

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

Note 5 – Stock-Based Compensation
 
The Company recognized the following share-based compensation expense in selling, general and administrative expenses in its Condensed Consolidated Statement of Income for the three and nine months ended September 30, 2014 and the three and nine months ended September 30, 2013:

 	 	Three Months Ended	 	 	Nine Months Ended	
 	 	September 30,	 	 	September 30,	
 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	
Stock options	 	$	171 	 	 	$	140 	 	 	$	492 	 	 	$	378 	
Nonvested stock awards and restricted stock units	 	 	593 	 	 	 	461 	 	 	 	1,758 	 	 	 	1,372 	
Employee stock purchase plan	 	 	18 	 	 	 	17 	 	 	 	54 	 	 	 	43 	
Non-elective and elective 401(k) matching contribution in stock	 	 	413 	 	 	 	347 	 	 	 	1,561 	 	 	 	1,283 	
Director stock ownership plan	 	 	32 	 	 	 	16 	 	 	 	94 	 	 	 	57 	
Total share-based compensation expense	 	$	1,227 	 	 	$	981 	 	 	$	3,959 	 	 	$	3,133 	
 
As of September 30, 2014 and September 30, 2013, the Company recorded $430 and $815, respectively, of excess tax benefits in capital in excess of par value on its Condensed Consolidated Balance Sheets related to stock option exercises. The Company’s estimated taxes payable was sufficient to fully recognize these benefits as cash inflows from financing activities in its Condensed Consolidated Statement of Cash Flows, which represented the Company’s estimate of cash savings through the nine months ended September 30, 2014 and September 30, 2013, respectively.
 
Stock option activity under all plans is as follows:
 
 	 	 	 	 	 	Weighted	
 	 	 	 	 	 	Average	
 	 	 	Weighted Average	 	Remaining	
 	Number of	 	Exercise Price per	 	Contractual	
 	Shares	 	Share	 	Term (years)	
Options outstanding at December 31, 2013	75,251 	 	$	44.49 	 	 	
Options granted	37,048 	 	 	73.47 	 	 	
Options exercised	(3,292)	 	 	42.24 	 	 	
Options outstanding at September 30, 2014	109,007 	 	$	54.41 	 	5.1 	
Options exercisable at September 30, 2014	40,628 	 	$	39.76 	 	4.0 	
 
As of September 30, 2014, the total intrinsic value of options outstanding was approximately $2,007, and the total intrinsic value of exercisable options was $1,330.  Intrinsic value is calculated as the difference between the current market price of the underlying security and the strike price of a related option.

9

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

A summary of the Company’s outstanding stock options at September 30, 2014 is as follows: 
 
 	 	 	 	 	 	 	 	 	Weighted	 	Weighted	 	Number	 	 	Weighted	
 	 	 	 	 	 	 	Number	 	Average	 	Average	 	Exercisable	 	 	Average	
Range of	 	Outstanding	 	Contractual	 	Exercise	 	at	 	 	Exercise	
Exercise Prices	 	at 9/30/2014	 	Life	 	Price	 	9/30/2014	 	 	Price	
$	0.00	-	 	$	10.00 	 	— 	 	— 	 	$	— 	 	— 	 	 	$	— 	
$	10.01 	-	 	$	20.00 	 	6,155 	 	2.3 	 	 	18.82 	 	6,155 	 	 	 	18.82 	
$	20.01 	-	 	$	30.00 	 	— 	 	— 	 	 	— 	 	— 	 	 	 	— 	
$	30.01 	-	 	$	40.00 	 	35,020 	 	4.1 	 	 	37.87 	 	23,954 	 	 	 	37.75 	
$	40.01 	-	 	$	50.00 	 	2,192 	 	4.7 	 	 	46.21 	 	1,462 	 	 	 	46.21 	
$	50.01 	-	 	$	60.00 	 	28,592 	 	5.4 	 	 	58.26 	 	9,057 	 	 	 	58.26 	
$	60.01 	-	 	$	70.00 	 	— 	 	— 	 	 	— 	 	— 	 	 	 	— 	
$	70.01 	-	 	$	80.00 	 	37,048 	 	6.4 	 	 	73.47 	 	— 	 	 	 	— 	
 	 	 	 	 	 	 	109,007 	 	5.1 	 	 	54.41 	 	40,628 	 	 	 	39.76 	
 
As of September 30, 2014, unrecognized compensation expense related to options granted during 2012 was $91, for options granted during 2013 was $304 and for options granted in 2014 was $658.
 
During the first quarter of 2014, the Company granted stock options under its LTIP plan that are subject only to time vesting over a three-year period.  For the purposes of determining the fair value of stock option awards, the Company uses the Black-Scholes option pricing model and the assumptions set forth in the table below:
 
 	2014 	 	
Number of options granted	 37,048 	 	
Dividend yield	2.00 	%	
Expected volatility	43.34 	%	
Risk-free interest rate	1.22 	%	
Expected term (years)	4.0 	 	
 
Approximately $68 and $159 of expense was recorded on these options during the three and nine months ended September 30, 2014, respectively.  The fair value of these awards is amortized on a straight-line basis over the vesting period of the awards.
 
Activity of nonvested shares granted under the Company’s LTIP plan is shown below:

 	 	 	Weighted	
 	 	 	Average Grant	
 	Number of	 	Date Fair Value	
 	Shares	 	(per share)	
Nonvested awards, December 31, 2013	115,984 	 	$	47.27 	
Granted	55,258 	 	$	73.80 	
Vested	(42,223)	 	$	40.51 	
Forfeited	(3,895)	 	$	37.01 	
Nonvested awards, September 30, 2014	125,124 	 	$	61.59 	
 
The fair value of the nonvested stock is based on the trading price of the Company’s common stock on the date of grant.  The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards.  As of September 30, 2014, unrecognized compensation expense related to these awards was $4,916 to be recognized over a weighted average remaining period of 2.37   years.

10

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

Activity of nonvested restricted stock units granted under the Company’s LTIP plan is shown below:

 	 	 	Weighted	
 	 	 	Average Grant	
 	Number of	 	Date Fair Value	
 	units	 	(per unit)	
Nonvested awards, December 31, 2013	4,018 	 	$	49.71 	
Granted	3,140 	 	$	75.52 	
Nonvested awards, September 30, 2014	7,158 	 	$	61.03 	
 
The fair value of the nonvested restricted stock units is based on the trading price of the Company’s common stock on the date of grant.  The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards.  As of September 30, 2014, unrecognized compensation expense related to these awards was $243 to be recognized over a weighted average remaining period of 2.01 years.
 
Employee Stock Purchase Plan
 
In 2000, the Board adopted an Employee Stock Purchase Plan (“ESPP”) whereby employees may purchase Company stock through a payroll deduction plan.  Purchases are made from the plan and credited to each participant’s account at the end of each month, the “Investment Date.” The purchase price of the stock is 85% of the fair market value on the Investment Date. The plan is compensatory and the 15% discount is expensed on the Investment Date. All employees, including officers, are eligible to participate in this plan. A participant may withdraw all uninvested payment balances credited to a participant’s account at any time.  An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.
 
2013 Director Stock Ownership Plan
 
In March 2013, the Company adopted the 2013 Director Stock Ownership Plan (the “Plan”), subject to the approval by the Company’s shareholders at the annual meeting, to encourage the Directors to increase their investment in the Company.  The Plan was approved at the Company’s May 2013 shareholders’ meeting.  The Plan authorizes the issuance of up to 75,000 shares of Quaker common stock in accordance with the terms of the Plan in payment of all or a portion of the annual cash retainer payable to each of the Company’s non-employee directors in 2013 and subsequent years during the term of the Plan.  Under the Plan, each director who, on May 1 st  of the applicable calendar year, owns less than 400% of the annual cash retainer for the applicable calendar year, divided by the average of the closing price of a share of Quaker Common Stock as reported by the composite tape of the New York Stock Exchange for the previous calendar year (the “Threshold Amount”), is required to receive 75% of the annual cash retainer in Quaker common stock and 25% of the retainer in cash, unless the director elects to receive a greater percentage of Quaker common stock (up to 100%) of the annual cash retainer for the applicable year.  Each director who owns more than the Threshold Amount may elect to receive common stock in payment of a percentage (up to 100%) of the annual cash retainer.  The annual retainer is $50 and the retainer payment date is June 1.  The Plan was adopted in order to replace the 2003 Director Stock Ownership Plan, which expired in May 2013.
 
Note 6 – Pension and Other Postretirement Benefits
 
The components of net periodic benefit cost for the three and nine months ended September 30, 2014 and September 30, 2013 are as follows:
 
 	Three Months Ended September 30,	 	Nine Months Ended September 30,	
 	 	 	 	 	 	 	Other	 	 	 	 	 	 	 	Other	
 	 	 	 	 	 	 	Postretirement	 	 	 	 	 	 	 	Postretirement	
 	Pension Benefits	 	Benefits	 	Pension Benefits	 	Benefits	
 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	
Service cost	$	716 	 	$	789 	 	$	5 	 	$	9 	 	$	2,186 	 	$	2,355 	 	$	15 	 	$	26 	
Interest cost and other	 	1,506 	 	 	1,394 	 	 	58 	 	 	46 	 	 	4,567 	 	 	4,172 	 	 	174 	 	 	138 	
Expected return on plan assets	 	(1,588)	 	 	(1,476)	 	 	— 	 	 	— 	 	 	(4,796)	 	 	(4,417)	 	 	— 	 	 	— 	
Actuarial loss amortization	 	763 	 	 	989 	 	 	16 	 	 	8 	 	 	2,311 	 	 	2,961 	 	 	48 	 	 	24 	
Prior service cost amortization	 	(21)	 	 	23 	 	 	— 	 	 	— 	 	 	830 	 	 	155 	 	 	— 	 	 	— 	
Net periodic benefit cost	$	1,376 	 	$	1,719 	 	$	79 	 	$	63 	 	$	5,098 	 	$	5,226 	 	$	237 	 	$	188 	

 
11

Table of Contents
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

During 2013, it was discovered that the Company’s subsidiary in the United Kingdom did not appropriately amend a trust for a legacy change in its pension scheme, as it related to a past retirement age equalization law.  Given the lack of an official deed to the pension trust, the effective date of the change to the Subsidiary’s pension scheme differed from the Company’s historical beliefs, but the extent of the potential exposure was not estimable.  In the first quarter of 2014, the Company recorded costs of $902, or $0.05 per diluted share, related to prior service cost and interest cost, to appropriately reflect the past plan amendment related to the retirement age equalization law.
 
Employer Contributions:
 
The Company previously disclosed in its financial statements for the year ended December 31, 2013, that it expected to make minimum cash contributions of $6,172 to its pension plans and $607 to its other postretirement benefit plan in 2014.  However, the Company exercised its option under the provisions of the Moving Ahead for Progress in the 21 st  Century Act (“MAP-21”) to reduce its current contributions.  Currently, the Company expects to make minimum cash contributions of $5,257 to its pension plans and $607 to its other postretirement benefit plan in 2014.  As of September 30, 2014, $4,757 and $432 of contributions had been made to the Company’s pension plans and its other postretirement benefit plans, respectively.
 
Note 7 – Other Income (Expense)
 
Other Income (Expense) includes:

 	 	Three Months Ended	 	 	Nine Months Ended	
 	 	September 30,	 	 	September 30,	
 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	
Change in fair value of acquisition-related earnout liability	 	$	— 	 	 	$	— 	 	 	$	— 	 	 	$	(675)	
Cost streamlining initiative	 	 	— 	 	 	 	(211)	 	 	 	— 	 	 	 	(211)	
Income from third party license fees	 	 	181 	 	 	 	168 	 	 	 	736 	 	 	 	716 	
Net foreign currency exchange gains (losses)	 	 	160 	 	 	 	(635)	 	 	 	(824)	 	 	 	(840)	
Net gain on fixed asset disposals	 	 	25 	 	 	 	29 	 	 	 	130 	 	 	 	267 	
Non-income tax refunds	 	 	531 	 	 	 	— 	 	 	 	531 	 	 	 	2,669 	
Other non-operating income	 	 	88 	 	 	 	27 	 	 	 	152 	 	 	 	193 	
Other non-operating expense	 	 	(71)	 	 	 	(63)	 	 	 	(167)	 	 	 	(157)	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total other income (expense), net	 	$	 914 	 	 	$	 (685)	 	 	$	 558 	 	 	$	 1,962 	

Note 8 – Income Taxes and Uncertain Income Tax Positions
 
The Company's effective tax rate for the first nine months of 2014 of 30.5% was higher than the first nine months of 2013 effective tax rate of 30.0%.  Both effective tax rates reflect decreases in reserves for uncertain tax positions due to the expiration of applicable statutes of limitations for certain tax years of approximately $0.06 and $0.13 per diluted share for the nine months ended September 30, 2014 and September 30, 2013, respectively.  The earnings per diluted share impact related to changes in uncertain tax positions was lower in the current year.  However, this impact was offset by recording tax expense at the statutory tax rate of 25% at one of the Company’s entities in its Asia/Pacific region in the prior year, while it awaited recertification of a concessionary tax rate.
 
As of September 30, 2014, the Company’s cumulative liability for gross unrecognized tax benefits was $11,317.  At December 31, 2013, the Company’s cumulative liability for gross unrecognized tax benefits was $12,596.
 
The Company continues to recognize interest and penalties associated with uncertain tax positions as a component of taxes on income before equity in net income of associated companies in its Condensed Consolidated Statement of Income. The Company recognized $(6) and $(64) for interest and $(99) and $(1) for penalties on its Condensed Consolidated Statement of Income for the three and nine months ended September 30, 2014, respectively, and recognized $39 and $(294) for interest and $101 and $342 for penalties on its Condensed Consolidated Statement of Income for the three and nine months ended September 30, 2013, respectively. As of September 30, 2014, the Company had accrued $1,900   for cumulative interest and $1,939 for cumulative penalties, compared to $2,108 for cumulative interest and $2,100 for cumulative penalties at December 31, 2013.
 
During the three months ended September 30, 2014, the Company recognized a decrease in its cumulative liability for gross unrecognized tax benefits of $802 due to the expiration of the applicable statutes of limitations for certain tax years.  During the three months ended September 30, 2013, the Company recognized a decrease in its cumulative liability for gross unrecognized tax benefits of $472 due to the expiration of the applicable statutes of limitations for certain tax years.

12

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

During the nine months ended September 30, 2014, the Company recognized a decrease in its cumulative liability for gross unrecognized tax benefits of $1,877 due to the expiration of the applicable statutes of limitations for certain tax years. During the nine months ended September 30, 2013, the Company recognized a decrease in its cumulative liability for gross unrecognized tax benefits of $2,167 due to the expiration of the applicable statutes of limitations for certain tax years.
 
The Company estimates that during the year ending December 31, 2014 it will reduce its cumulative liability for gross unrecognized tax benefits by approximately $1,900 to $2,000 due to the expiration of the statute of limitations with regard to certain tax positions. This estimated reduction in the cumulative liability for unrecognized tax benefits does not consider any increase in liability for unrecognized tax benefits with regard to existing tax positions or any increase in cumulative liability for unrecognized tax benefits with regard to new tax positions for the year ending December 31, 2014.
 
The Company and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various state and foreign tax jurisdictions. Tax years that remain subject to examination by major tax jurisdictions include Brazil from 2000, the Netherlands from 2008, the United Kingdom from 2009, Spain, China and Italy from 2010, the United States from 2011, and various domestic state tax jurisdictions from 1993.
 
During the second quarter of 2012, the Italian tax authorities initiated a transfer pricing audit of the Company’s Italian subsidiary.  On July 7, 2012, the Company received a preliminary tax report related to this transfer pricing audit, which proposed several adjustments to the taxable income of the subsidiary.  During the fourth quarter of 2012, the Company’s Italian subsidiary received an assessment for the tax year 2007, which the Company appealed during the first quarter of 2013.  On September 16, 2013, the Provincial Tax Court of Varese delivered a decision confirming the Italian tax authorities’ proposed adjustment to the taxable income of the subsidiary, but denying the proposed assessment of penalties.  On January 24, 2014, the Company’s Italian subsidiary appealed the decision of the Provincial Tax Court of Varese.  On March 7, 2014, the Italian tax authorities appealed the decision of the Provincial Tax Court denying the assessment of penalties.
 
On November 29, 2013, the Italian tax authorities issued a tax assessment for the tax year 2008, raising identical issues as the assessment for 2007, noted above.  On March 28, 2014, the Company filed an appeal with the Provincial Tax Court of Varese.  The Company filed a request for competent authority relief between the Italian and Dutch tax authorities, and between the Italian and Spanish tax authorities.
 
On August 4, 2014, the Italian tax authorities issued a tax assessment for the tax year 2009, raising identical issues as the assessments for 2007 and 2008, noted above.
 
Related to each of the above events, the Company and outside counsel believe we should prevail on the merits of each case.  Therefore, the Company does not believe it has any exposures warranting an uncertain tax position reserve as of September 30, 2014.
 
Note 9 – Earnings Per Share
 
The following table summarizes earnings per share calculations for the three and nine months ended September 30, 2014 and September 30, 2013:
 
 	 	Three Months Ended	 	 	Nine Months Ended	
 	 	 	September 30,	 	 	 	September 30,	
 	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	
Basic earnings per common share	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income attributable to Quaker Chemical Corporation	 	$	15,696 	 	 	 $	12,551 	 	 	$	43,853 	 	 	 $	42,253 	
Less: income allocated to participating securities	 	 	(140)	 	 	 	(109)	 	 	 	(385)	 	 	 	(358)	
Net income available to common shareholders	 	$	15,556 	 	 	$	12,442 	 	 	$	43,468 	 	 	$	41,895 	
Basic weighted average common shares outstanding	 	 	13,133,668 	 	 	 	13,062,417 	 	 	 	13,114,553 	 	 	 	13,034,289 	
Basic earnings per common share	 	$	1.18 	 	 	$	0.95 	 	 	$	3.31 	 	 	$	3.21 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Diluted earnings per common share	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income attributable to Quaker Chemical Corporation	 	$	15,696 	 	 	$	12,551 	 	 	$	43,853 	 	 	$	42,253 	
Less: income allocated to participating securities	 	 	(140)	 	 	 	(109)	 	 	 	(384)	 	 	 	(357)	
Net income available to common shareholders	 	$	15,556 	 	 	$	12,442 	 	 	$	43,469 	 	 	$	41,896 	
Basic weighted average common shares outstanding	 	 	13,133,668 	 	 	 	13,062,417 	 	 	 	13,114,553 	 	 	 	13,034,289 	
Effect of dilutive securities	 	 	22,673 	 	 	 	22,488 	 	 	 	21,147 	 	 	 	25,909 	
Diluted weighted average common shares outstanding	 	 	13,156,341 	 	 	 	13,084,905 	 	 	 	13,135,700 	 	 	 	13,060,198 	
Diluted earnings per common share	 	$	1.18 	 	 	$	0.95 	 	 	$	3.31 	 	 	$	3.21 	

 
13

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

The following number of stock options and restricted stock units are not included in diluted earnings per share since the effect would have been anti-dilutive: 6,146 and 2,858 for the three months ended September 30, 2014 and September 30, 2013, respectively, and 5,254 and 4,118 for the nine months ended September 30, 2014 and September 30, 2013, respectively.
 
Note 10 – Goodwill and Other Intangible Assets
 
The Company completed its annual impairment assessment as of the end of the third quarter of 2014 and no impairment charge was warranted.  The estimated fair value of each of the Company’s reporting units substantially exceeded its carrying value, with none of the Company’s reporting units at risk for failing step one of the goodwill impairment test.  In addition, the Company has recorded no impairment charges in the past.
 
Changes in the carrying amount of goodwill for the nine months ended September 30, 2014 were as follows:
 
 	 	North	 	 	 	 	 	 	 	 	 	 	South	 	 	 	 	
 	 	America	 	 	EMEA	 	 	Asia/Pacific	 	 	America	 	 	Total	
Balance as of December 31, 2013	 	$	28,127 	 	 	$	11,184 	 	 	$	15,018 	 	 	$	3,822 	 	 	$	58,151 	
Goodwill additions	 	 	13,429 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	13,429 	
Currency translation adjustments	 	 	 (611)	 	 	 	 (341)	 	 	 	 (458)	 	 	 	 (117)	 	 	 	 (1,527)	
Balance as of September 30, 2014	 	$	40,945 	 	 	$	10,843 	 	 	$	14,560 	 	 	$	3,705 	 	 	$	70,053 	
 
Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of September 30, 2014 and December 31, 2013 are as follows:
 
 	 	Gross Carrying	 	 	Accumulated	
 	 	Amount	 	 	Amortization	
Definite-lived intangible assets	 	2014 	 	 	2013 	 	 	2014 	 	 	2013 	
Customer lists and rights to sell	 	$	53,894 	 	 	$	33,559 	 	 	$	11,812 	 	 	$	10,221 	
Trademarks and patents	 	 	6,628 	 	 	 	6,838 	 	 	 	3,628 	 	 	 	3,202 	
Formulations and product technology	 	 	15,338 	 	 	 	5,808 	 	 	 	3,968 	 	 	 	3,709 	
Other	 	 	6,540 	 	 	 	5,544 	 	 	 	4,791 	 	 	 	4,445 	
Total	 	$	82,400 	 	 	$	51,749 	 	 	$	24,199 	 	 	$	21,577 	
 
The Company recorded $2,754 and $2,621 of amortization expense in the nine months ended September 30, 2014 and September 30, 2013, respectively. Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:
 
For the year ended December 31, 2014	$	4,198 	
For the year ended December 31, 2015	$	5,777 	
For the year ended December 31, 2016	$	5,302 	
For the year ended December 31, 2017	$	4,643 	
For the year ended December 31, 2018	$	4,619 	
For the year ended December 31, 2019	$	4,543 	
 
The Company has two indefinite-lived intangible assets totaling $1,100 for trademarks at September 30, 2014.
 
Note 11 – Debt
 
The Company’s primary credit line is a $300,000 syndicated multicurrency credit agreement with Bank of America, N.A. (administrative agent) and certain other major financial institutions, which matures in June 2018.  The maximum amount available under this facility can be increased to $400,000 at the Company’s option if the lenders agree and the Company satisfies certain conditions.  Access to this facility is dependent on meeting certain financial, acquisition and other covenants, but primarily depends on the Company’s consolidated leverage ratio calculation, which cannot exceed 3.50 to 1.  At September 30, 2014 and December 31, 2013, the consolidated leverage ratio was below 1.0 to 1 and the Company was also in compliance with all of the facility’s other covenants.  At September 30, 2014, the Company had approximately $45,000 outstanding under this facility.  At December 31, 2013, the Company had no borrowings outstanding under this facility.

14

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

Note 12 – Equity and Noncontrolling Interest
 
The following table presents the changes in equity and noncontrolling interest for the three and nine months ended September 30, 2014 and September 30, 2013:

 	 	 	 	 	 	 	 	 	 	 	 	 	 	Accumulated	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Capital in	 	 	 	 	 	 	Other	 	 	 	 	 	 	 	 	
 	 	Common	 	 	Excess of	 	 	Retained	 	 	Comprehensive	 	 	Noncontrolling	 	 	 	 	
 	 	Stock	 	 	Par Value	 	 	Earnings	 	 	Loss	 	 	Interest	 	 	Total	
Balance at June 30, 2014	 	$	13,242 	 	 	$	95,508 	 	 	$	279,161 	 	 	$	(31,587)	 	 	$	8,386 	 	 	$	364,710 	
Net income	 	 	— 	 	 	 	— 	 	 	 	15,696 	 	 	 	— 	 	 	 	423 	 	 	 	16,119 	
Amounts reported in other comprehensive income	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(9,826)	 	 	 	(246)	 	 	 	(10,072)	
Dividends ($0.30 per share)	 	 	— 	 	 	 	— 	 	 	 	(3,981)	 	 	 	— 	 	 	 	— 	 	 	 	(3,981)	
Distributions to noncontrolling affiliate shareholders	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(1,149)	 	 	 	(1,149)	
Acquisition of noncontrolling interest	 	 	— 	 	 	 	7 	 	 	 	— 	 	 	 	— 	 	 	 	148 	 	 	 	155 	
Share issuance and equity-based compensation plans	 	 	27 	 	 	 	1,039 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	1,066 	
Excess tax benefit from stock option exercises	 	 	— 	 	 	 	163 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	163 	
Balance at September 30, 2014	 	$	13,269 	 	 	$	96,717 	 	 	$	290,876 	 	 	$	(41,413)	 	 	$	7,562 	 	 	$	367,011 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at June 30, 2013	 	$	13,168 	 	 	$	97,085 	 	 	$	238,580 	 	 	$	(45,252)	 	 	$	8,776 	 	 	$	312,357 	
Net income	 	 	— 	 	 	 	— 	 	 	 	12,551 	 	 	 	— 	 	 	 	754 	 	 	 	13,305 	
Amounts reported in other comprehensive income	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	2,014 	 	 	 	(255)	 	 	 	1,759 	
Dividends ($0.25 per share)	 	 	— 	 	 	 	— 	 	 	 	(3,298)	 	 	 	— 	 	 	 	— 	 	 	 	(3,298)	
Distributions to noncontrolling affiliate shareholders	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(30)	 	 	 	(30)	
Share issuance and equity-based compensation plans	 	 	19 	 	 	 	368 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	387 	
Excess tax benefit from stock option exercises	 	 	— 	 	 	 	363 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	363 	
Balance at September 30, 2013	 	$	13,187 	 	 	$	97,816 	 	 	$	247,833 	 	 	$	(43,238)	 	 	$	9,245 	 	 	$	324,843 	

 
15

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

 
 	 	 	 	 	 	 	 	 	 	 	 	 	 	Accumulated	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Capital in	 	 	 	 	 	 	Other	 	 	 	 	 	 	 	 	
 	 	Common	 	 	Excess of	 	 	Retained	 	 	Comprehensive	 	 	Noncontrolling	 	 	 	 	
 	 	Stock	 	 	Par Value	 	 	Earnings	 	 	Loss	 	 	Interest	 	 	Total	
Balance at December 31, 2013	 	$	13,196 	 	 	$	99,038 	 	 	$	258,285 	 	 	$	(34,700)	 	 	$	8,877 	 	 	$	344,696 	
Net income	 	 	— 	 	 	 	— 	 	 	 	43,853 	 	 	 	— 	 	 	 	1,517 	 	 	 	45,370 	
Amounts reported in other comprehensive income	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(6,713)	 	 	 	(47)	 	 	 	(6,760)	
Dividends ($0.85 per share)	 	 	— 	 	 	 	— 	 	 	 	(11,262)	 	 	 	— 	 	 	 	— 	 	 	 	(11,262)	
Distributions to noncontrolling affiliate shareholders	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(1,806)	 	 	 	(1,806)	
Acquisition of noncontrolling interest	 	 	— 	 	 	 	(6,443)	 	 	 	— 	 	 	 	— 	 	 	 	(979)	 	 	 	(7,422)	
Share issuance and equity-based compensation plans	 	 	73 	 	 	 	3,692 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	3,765 	
Excess tax benefit from stock option exercises	 	 	— 	 	 	 	430 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	430 	
Balance at September 30, 2014	 	$	13,269 	 	 	$	96,717 	 	 	$	290,876 	 	 	$	(41,413)	 	 	$	7,562 	 	 	$	367,011 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at December 31, 2012	 	$	13,095 	 	 	$	94,470 	 	 	$	215,390 	 	 	$	(41,855)	 	 	$	8,576 	 	 	$	289,676 	
Net income	 	 	— 	 	 	 	— 	 	 	 	42,253 	 	 	 	— 	 	 	 	1,918 	 	 	 	44,171 	
Amounts reported in other comprehensive income	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(1,383)	 	 	 	(1,219)	 	 	 	(2,602)	
Dividends ($0.745 per share)	 	 	— 	 	 	 	— 	 	 	 	(9,810)	 	 	 	— 	 	 	 	— 	 	 	 	(9,810)	
Distributions to noncontrolling affiliate shareholders	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(30)	 	 	 	(30)	
Share issuance and equity-based compensation plans	 	 	92 	 	 	 	2,531 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	2,623 	
Excess tax benefit from stock option exercises	 	 	— 	 	 	 	815 	 	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	815 	
Balance at September 30, 2013	 	$	13,187 	 	 	$	97,816 	 	 	$	247,833 	 	 	$	(43,238)	 	 	$	9,245 	 	 	$	324,843 	
 
The following tables show the reclassifications from and resulting balances of accumulated other comprehensive loss for the three and nine months ended September 30, 2014 and September 30, 2013:

 	 	 	 	 	 	 	 	 	 	Unrealized	 	 	 	 	
 	 	Currency	 	 	Defined	 	 	gain (loss) in	 	 	 	 	
 	 	translation	 	 	benefit	 	 	available-for-	 	 	 	 	
 	 	adjustments	 	 	pension plans	 	 	sale securities	 	 	Total	
Balance at June 30, 2014	 	$	3,208 	 	 	$	(36,274)	 	 	$	1,479 	 	 	$	(31,587)	
Other comprehensive (loss) income before reclassifications	 	 	(11,409)	 	 	 	1,698 	 	 	 	(24)	 	 	 	(9,735)	
Amounts reclassified from accumulated other comprehensive loss	 	 	— 	 	 	 	759 	 	 	 	(300)	 	 	 	459 	
Current period other comprehensive (loss) income	 	 	(11,409)	 	 	 	2,457 	 	 	 	(324)	 	 	 	(9,276)	
Related tax amounts	 	 	— 	 	 	 	(660)	 	 	 	110 	 	 	 	(550)	
Net current period other comprehensive (loss) income	 	 	(11,409)	 	 	 	1,797 	 	 	 	(214)	 	 	 	(9,826)	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at September 30, 2014	 	$	(8,201)	 	 	$	(34,477)	 	 	$	1,265 	 	 	$	(41,413)	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at June 30, 2013	 	$	(1,646)	 	 	$	(45,046)	 	 	$	1,440 	 	 	$	(45,252)	
Other comprehensive income (loss) before reclassifications	 	 	2,527 	 	 	 	(1,016)	 	 	 	494 	 	 	 	2,005 	
Amounts reclassified from accumulated other comprehensive loss	 	 	— 	 	 	 	1,019 	 	 	 	(998)	 	 	 	21 	
Current period other comprehensive income (loss)	 	 	2,527 	 	 	 	3 	 	 	 	(504)	 	 	 	2,026 	
Related tax amounts	 	 	— 	 	 	 	(183)	 	 	 	171 	 	 	 	(12)	
Net current period other comprehensive income (loss)	 	 	2,527 	 	 	 	(180)	 	 	 	(333)	 	 	 	2,014 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at September 30, 2013	 	$	881 	 	 	$	(45,226)	 	 	$	1,107 	 	 	$	(43,238)	

 
16

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

 
 	 	 	 	 	 	 	 	 	 	Unrealized	 	 	 	 	
 	 	Currency	 	 	Defined	 	 	gain (loss) in	 	 	 	 	
 	 	translation	 	 	benefit	 	 	available-for-	 	 	 	 	
 	 	adjustments	 	 	pension plans	 	 	sale securities	 	 	Total	
Balance at December 31, 2013	 	$	1,152 	 	 	$	(37,433)	 	 	$	1,581 	 	 	$	(34,700)	
Other comprehensive (loss) income before reclassifications	 	 	(9,353)	 	 	 	1,842 	 	 	 	1,481 	 	 	 	(6,030)	
Amounts reclassified from accumulated other comprehensive loss	 	 	— 	 	 	 	2,290 	 	 	 	(1,959)	 	 	 	331 	
Current period other comprehensive (loss) income	 	 	(9,353)	 	 	 	4,132 	 	 	 	(478)	 	 	 	(5,699)	
Related tax amounts	 	 	— 	 	 	 	(1,176)	 	 	 	162 	 	 	 	(1,014)	
Net current period other comprehensive (loss) income	 	 	(9,353)	 	 	 	2,956 	 	 	 	(316)	 	 	 	(6,713)	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at September 30, 2014	 	$	(8,201)	 	 	$	(34,477)	 	 	$	1,265 	 	 	$	(41,413)	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at December 31, 2012	 	$	3,336 	 	 	$	(46,914)	 	 	$	1,723 	 	 	$	(41,855)	
Other comprehensive (loss) income before reclassifications	 	 	(2,455)	 	 	 	(468)	 	 	 	1,353 	 	 	 	(1,570)	
Amounts reclassified from accumulated other comprehensive loss	 	 	— 	 	 	 	3,140 	 	 	 	(2,286)	 	 	 	854 	
Current period other comprehensive (loss) income	 	 	(2,455)	 	 	 	2,672 	 	 	 	(933)	 	 	 	(716)	
Related tax amounts	 	 	— 	 	 	 	(984)	 	 	 	317 	 	 	 	(667)	
Net current period other comprehensive (loss) income	 	 	(2,455)	 	 	 	1,688 	 	 	 	(616)	 	 	 	(1,383)	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at September 30, 2013	 	$	881 	 	 	$	(45,226)	 	 	$	1,107 	 	 	$	(43,238)	
 
Approximately 30% and 70% of the amounts reclassified from accumulated other comprehensive loss to the Condensed Consolidated Statement of Income for defined benefit retirement plans during the three and nine months ended September 30, 2014 and September 30, 2013 were recorded in cost of goods sold and SG&A, respectively.  See Note 6 of Notes to Condensed Consolidated Financial Statements for further information.  All reclassifications related to unrealized gain (loss) in available-for-sale securities relate to the Company’s equity interest in a captive insurance company and are recorded in equity in net income of associated companies.  The amounts reported in other comprehensive income for noncontrolling interest are related to currency translation adjustments.
 
Note 13 – Business Acquisitions
 
In August 2014, the Company acquired ECLI Products, LLC (“ECLI”), a specialty grease manufacturer for its North American reportable operating segment for approximately $52,000. ECLI specializes in greases for OEM first-fill customers across several industry sectors, including automotive, industrial, aerospace/military, electronics, office automation and natural resources.  The Company allocated the purchase price to $31,110 of intangible assets, comprised of trademarks and formulations, to be amortized over 10 years; customer relationships, to be amortized over 15 years; and a non-compete agreement, to be amortized over 5 years. In addition, the Company recorded $13,429 of goodwill, all of which will be tax deductible.  As of September 30, 2014, the allocation of the purchase price, highlighted in the table below, has not been finalized.

 	 	 	
2014 Acquisition	 	ECLI Products, LLC	
Current assets	 	$	6,908 	
Fixed assets	 	 	2,712 	
Intangibles	 	 	31,110 	
Goodwill	 	 	13,429 	
Total assets purchased	 	 	54,159 	
Current liabilities	 	 	(2,159)	
Total liabilities assumed	 	 	(2,159)	
Cash paid for an acquisition	 	$	52,000 	
 
Included in the ECLI acquisition was approximately $53 of cash acquired.
 
In June 2014, the Company acquired the remaining 49% ownership interest in its Australian affiliate, Quaker Chemical (Australasia) Pty. Limited ("QCA") for Australian Dollars $8,000, or approximately $7,577, from its joint venture partner, Nuplex Industries.  QCA is a part of the Asia/Pacific reportable operating segment.  As this acquisition was a change in an existing controlling ownership, the

17

Table of Contents
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

Company recorded $6,450 of excess of purchase price over the carrying value of the noncontrolling interest in Additional Paid in Capital.
 
In May 2013, the Company acquired a business that primarily related to tin plating for its North American reportable operating segment for net consideration of approximately $1,831.  The Company allocated the purchase price to $830 of intangible assets, comprised of formulations, to be amortized over 10 years; a non-competition agreement, to be amortized over 4 years; and a customer list, to be amortized over 10 years.  In addition, the Company recorded $277 of goodwill, all of which will be tax deductible.  The remaining purchase price was allocated between the acquisition date fair value of inventory purchased of $454 and fixed assets purchased of $270.
 
In January 2013, the Company acquired a chemical milling maskants distribution network for net consideration of approximately $647, which was assigned to the North America reportable operating segment.  The Company also assumed an additional $100 hold-back of consideration for potential indemnity obligations, which was paid to the former shareholders during the first quarter of 2014.  The acquired intangible was allocated to the Company’s customer lists and rights to sell intangible assets and will be amortized over 5 years.
 
Certain pro forma and other disclosures have not been provided for these acquisitions because the effects were not material.

Note 14 – Fair Value Measurements
 
The Company values its company-owned life insurance policies, various deferred compensation assets and liabilities, and certain acquisition-related consideration at fair value.  The Company’s assets and liabilities subject to fair value measurement are as follows:
 
 	 	 	 	 	 	Fair Value Measurements at September 30, 2014	
 	 	Fair Value	 	 	Using Fair Value Hierarchy	
 	 	as of	 	 	 	 	 	 	 	 	 	 	 	 	
Assets	 	September 30, 2014	 	 	Level 1	 	 	Level 2	 	 	Level 3	
Company-owned life insurance	 	$	1,323 	 	 	$	— 	 	 	$	1,323 	 	 	$	— 	
Company-owned life insurance - Deferred compensation assets	 	 	316 	 	 	 	— 	 	 	 	316 	 	 	 	— 	
Other deferred compensation assets	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Large capitalization registered investment companies	 	 	68 	 	 	 	68 	 	 	 	— 	 	 	 	— 	
Mid capitalization registered investment companies	 	 	6 	 	 	 	6 	 	 	 	— 	 	 	 	— 	
Small capitalization registered investment companies	 	 	12 	 	 	 	12 	 	 	 	— 	 	 	 	— 	
International developed and emerging markets registered investment	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
                companies	 	 	38 	 	 	 	38 	 	 	 	— 	 	 	 	— 	
Fixed income registered investment companies	 	 	6 	 	 	 	6 	 	 	 	— 	 	 	 	— 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	1,769 	 	 	$	130 	 	 	$	1,639 	 	 	$	— 	
 
 	 	 	 	 	 	Fair Value Measurements at September 30, 2014	
 	 	Fair Value	 	 	Using Fair Value Hierarchy	
 	 	as of	 	 	 	 	 	 	 	 	 	 	 	 	
Liabilities	 	September 30, 2014	 	 	Level 1	 	 	Level 2	 	 	Level 3	
Deferred compensation liabilities	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Large capitalization registered investment companies	 	$	390 	 	 	$	390 	 	 	$	— 	 	 	$	— 	
Mid capitalization registered investment companies	 	 	102 	 	 	 	102 	 	 	 	— 	 	 	 	— 	
Small capitalization registered investment companies	 	 	85 	 	 	 	85 	 	 	 	— 	 	 	 	— 	
International developed and emerging markets registered investment	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
                  companies	 	 	187 	 	 	 	187 	 	 	 	— 	 	 	 	— 	
Fixed income registered investment companies	 	 	40 	 	 	 	40 	 	 	 	— 	 	 	 	— 	
Fixed general account	 	 	158 	 	 	 	— 	 	 	 	158 	 	 	 	— 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	962 	 	 	$	804 	 	 	$	158 	 	 	$	— 	

 
18

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

 
 	 	 	 	 	 	Fair Value Measurements at December 31, 2013	
 	 	Fair Value	 	 	Using Fair Value Hierarchy	
 	 	as of	 	 	 	 	 	 	 	 	 	 	 	 	
Assets	 	December 31, 2013	 	 	Level 1	 	 	Level 2	 	 	Level 3	
Company-owned life insurance	 	$	1,885 	 	 	$	— 	 	 	$	1,885 	 	 	$	— 	
Company-owned life insurance - Deferred compensation assets	 	 	409 	 	 	 	— 	 	 	 	409 	 	 	 	— 	
Other deferred compensation assets	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Large capitalization registered investment companies	 	 	74 	 	 	 	74 	 	 	 	— 	 	 	 	— 	
Mid capitalization registered investment companies	 	 	6 	 	 	 	6 	 	 	 	— 	 	 	 	— 	
Small capitalization registered investment companies	 	 	13 	 	 	 	13 	 	 	 	— 	 	 	 	— 	
International developed and emerging markets registered investment	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
                 companies	 	 	40 	 	 	 	40 	 	 	 	— 	 	 	 	— 	
Fixed income registered investment companies	 	 	7 	 	 	 	7 	 	 	 	— 	 	 	 	— 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	2,434 	 	 	$	140 	 	 	$	2,294 	 	 	$	— 	
 
 	 	 	 	 	 	Fair Value Measurements at December 31, 2013	
 	 	Fair Value	 	 	Using Fair Value Hierarchy	
 	 	as of	 	 	 	 	 	 	 	 	 	 	 	 	
Liabilities	 	December 31, 2013	 	 	Level 1	 	 	Level 2	 	 	Level 3	
Deferred compensation liabilities	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Large capitalization registered investment companies	 	$	405 	 	 	$	405 	 	 	$	— 	 	 	$	— 	
Mid capitalization registered investment companies	 	 	109 	 	 	 	109 	 	 	 	— 	 	 	 	— 	
Small capitalization registered investment companies	 	 	95 	 	 	 	95 	 	 	 	— 	 	 	 	— 	
International developed and emerging markets registered investment	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
                 companies	 	 	205 	 	 	 	205 	 	 	 	— 	 	 	 	— 	
Fixed income registered investment companies	 	 	43 	 	 	 	43 	 	 	 	— 	 	 	 	— 	
Fixed general account	 	 	167 	 	 	 	— 	 	 	 	167 	 	 	 	— 	
Acquisition-related consideration	 	 	4,876 	 	 	 	— 	 	 	 	— 	 	 	 	4,876 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	5,900 	 	 	$	857 	 	 	$	167 	 	 	$	4,876 	
 
The fair values of Company-owned life insurance (“COLI”) and COLI deferred compensation assets are based on quotes for like instruments with similar credit ratings and terms.  The fair values of other deferred compensation assets and liabilities are based on quoted prices in active markets.  The fair value of the Summit earnout was based on unobservable inputs and was classified as Level 3.  At December 31, 2013, the significant input and assumption was the discount rate used to present value the liability.  The fair value of the obligation related to a non-competition agreement was also based on unobservable inputs and was classified as Level 3.  The significant inputs and assumptions for the obligation related to the non-competition agreement was management’s estimate of the discount rate used to present value the liability.  A significant change in any Level 3 assumption in isolation would have resulted in increases or decreases to the fair value measurements of the acquisition-related consideration.
 
Changes in the fair value of the Level 3 liabilities during the nine months ended September 30, 2014 were as follows:
 
 	 	 	 	Non-competition	 	 	 	 	
 	Earnout	 	 	Agreement	 	 	 	 	
 	Summit	 	 	Obligation	 	 	Total	
Balance at December 31, 2013	$	 	4,697 	 	 	$	179 	 	 	$	4,876 	
Interest accretion	 	 	12 	 	 	 	8 	 	 	 	20 	
Payments	 	 	 (4,709)	 	 	 	(187)	 	 	 	(4,896)	
Balance at September 30, 2014	$	 	— 	 	 	$	— 	 	 	$	— 	
 
The Company settled its obligation related to the Summit earnout liability with a payment of $4,709 to its former shareholders in April 2014.  In addition, the Company made its final payment related to the non-competition agreement obligation in the third quarter of 2014.

19

Table of Contents 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

Note 15 – Commitments and Contingencies
 
In April of 1992, the Company identified certain soil and groundwater contamination at AC Products, Inc. (“ACP”), a wholly owned subsidiary.  In voluntary coordination with the Santa Ana California Regional Water Quality Board (“SACRWQB”), ACP has been remediating the contamination, the principal contaminant of which is perchloroethylene (“PERC”).  In 2004, the Orange County Water District (“OCWD”) filed a civil complaint against ACP and other parties seeking to recover compensatory and other damages related to the investigation and remediation of contaminated groundwater.  Pursuant to a settlement agreement entered into by ACP and OCWD in 2007, ACP agreed, among other things, to operate two groundwater treatment systems to hydraulically contain groundwater contamination emanating from ACP’s site until the concentrations of PERC released by ACP fell below the current Federal maximum contaminant level for four consecutive quarterly sampling events.  In February of this year, ACP, with the consent of OCWD and SACRWQB, ceased operation at one of its two groundwater treatment systems, as it had met the above condition for closure.  Based on the most recent modeling, it is estimated that the remaining system will operate for another fifteen months to three years.
 
As of September 30, 2014, the Company believes that the range of potential-known liabilities associated with the balance of ACP water remediation program is approximately $425 to $1,050, for which the Company has sufficient reserves.  This represents an increased range of estimated potential-known liabilities from prior reporting periods, as ACP has lengthened, by a year for the low end and by a year and three quarters for the high end, its expectation of meeting the settlement agreement’s closure standards.  The low and high ends of the range are based on the length of operation of the treatment system as determined by groundwater modeling.  Costs of operation include the operation and maintenance of the extraction well, groundwater monitoring and program management.
 
The Company believes, although there can be no assurance regarding the outcome of other unrelated environmental matters, that it has made adequate accruals for costs associated with other environmental problems of which it is aware.  Approximately $171 and $205 was accrued at September 30, 2014 and December 31, 2013, respectively, to provide for such anticipated future environmental assessments and remediation costs.
 
An inactive subsidiary of the Company that was acquired in 1978 sold certain products containing asbestos, primarily on an installed basis, and is among the defendants in numerous lawsuits alleging injury due to exposure to asbestos.  The subsidiary discontinued operations in 1991 and has no remaining assets other than the proceeds from insurance settlements received.  To date, the overwhelming majority of these claims have been disposed of without payment and there have been no adverse judgments against the subsidiary.  Based on a continued analysis of the existing and anticipated future claims against this subsidiary, it is currently projected that the subsidiary’s total liability over the next 50 years for these claims is approximately $2,700 (excluding costs of defense). Although the Company has also been named as a defendant in certain of these cases, no claims have been actively pursued against the Company, and the Company has not contributed to the defense or settlement of any of these cases pursued against the subsidiary. These cases were handled by the subsidiary’s primary and excess insurers who had agreed in 1997 to pay all defense costs and be responsible for all damages assessed against the subsidiary arising out of existing and future asbestos claims up to the aggregate limits of the policies.  A significant portion of this primary insurance coverage was provided by an insurer that is now insolvent, and the other primary insurers have asserted that the aggregate limits of their policies have been exhausted.  The subsidiary challenged the applicability of these limits to the claims being brought against the subsidiary.  In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in late 2005 and early 2007 for $15,000 and $20,000, respectively.  The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation.  During the third quarter of 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier will pay 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims for a minimum of five years beginning July 1, 2007.  The agreement continues until terminated and can only be terminated by either party by providing the other party with a minimum of two years prior written notice.  As of September 30, 2014, no notice of termination has been given under this agreement.  At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits.  The Company also believes that, if the coverage issues under the primary policies with the remaining carrier are resolved adversely to the subsidiary and all settlement proceeds were used, the subsidiary may have limited additional coverage from a state guarantee fund established following the insolvency of one of the subsidiary’s primary insurers.  Nevertheless, liabilities in respect of claims may exceed the assets and coverage available to the subsidiary.
 
If the subsidiary’s assets and insurance coverage were to be exhausted, claimants of the subsidiary may actively pursue claims against the Company because of the parent-subsidiary relationship.  Although asbestos litigation is particularly difficult to predict, especially with respect to claims that are currently not being actively pursued against the Company, the Company does not believe that such claims would have merit or that the Company would be held to have liability for any unsatisfied obligations of the subsidiary as a result of such claims.  After evaluating the nature of the claims filed against the subsidiary and the small number of such claims that have resulted in any payment, the potential availability of additional insurance coverage at the subsidiary level, the additional

20

Table of Contents
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except share and per share amounts)
(Unaudited)

availability of the Company’s own insurance and the Company’s strong defenses to claims that it should be held responsible for the subsidiary’s obligations because of the parent-subsidiary relationship, the Company believes it is not probable that the Company will incur any material losses.  The Company has been successful to date having claims naming it dismissed during initial proceedings. Since the Company may be in this early stage of litigation for some time, it is not possible to estimate additional losses or range of loss, if any.
 
As initially disclosed in the Company’s second quarter 2010 Form 10-Q, one of the Company’s subsidiaries may have paid certain value-added-taxes (“VAT”) incorrectly and, in certain cases, may not have collected sufficient VAT from certain customers.  The VAT rules and regulations at issue are complex, vary among the jurisdictions and can be contradictory, in particular as to how they relate to the subsidiary’s products and to sales between jurisdictions.
 
Since its inception, the subsidiary had been consistent in its VAT collection and remittance practices and had never been contacted by any tax authority relative to VAT.  The subsidiary later determined that for certain products, a portion of the VAT was incorrectly paid and that the total VAT due exceeds the amount originally collected and remitted by the subsidiary.  In response, the subsidiary modified its VAT invoicing and payment procedures to eliminate or mitigate future exposures.  In 2010, three jurisdictions contacted the subsidiary and, since then, the subsidiary has either participated in an amnesty program or entered into a settlement whereby it paid a reduced portion of the amounts owed in resolution of those jurisdictions’ claims.  In late 2013, an additional jurisdiction issued an assessment against the subsidiary for certain tax years.  The subsidiary has filed an appeal of the assessment alleging certain errors by such jurisdiction related to the assessment.
 
In analyzing the subsidiary’s exposure, it is difficult to estimate both the probability and the amount of any potential liabilities due to a number of factors, including: the decrease in exposure over time due to applicable statutes of limitations and actions taken by the subsidiary, the joint liability of customers and suppliers for a portion of the VAT, the availability of a VAT refund for VAT incorrectly paid through an administrative process, any amounts which may have been or will be paid by customers, as well as the timing and structure of any tax amnesties or settlements.  In addition, interest and penalties on any VAT due can be a multiple of the base tax.  The subsidiary may contest any tax assessment administratively and/or judicially for an extended period of time, but may ultimately resolve its disputes through participation in tax amnesty programs, which are a common practice for settling tax disputes in the jurisdictions in question and which have historically occurred on a regular basis, resulting in significant reductions of interest and penalties.  Also, the timing of payments and refunds of VAT may not be contemporaneous, and, if additional VAT is owed, it may not be fully recoverable from customers.  As a result, this matter has the potential to have a material adverse impact on the Company’s financial position, liquidity and capital resources and the results of operations.
 
In 2010, the Company recorded a net charge of $4,132, which consisted of a net $3,901 charge related to two tax dispute settlements entered into by the subsidiary, as well as a net $231 charge representing management’s best estimate based on the information available to it, including the factors noted above, of the amount that ultimately may be paid related to the other jurisdiction that has made inquiries.  At September 30, 2014 and December 31, 2013, the Company had no remaining accrual, related to the 2010 charges for payments to be made under the tax dispute settlements entered into by the subsidiary, noted above.  In the fourth quarter of 2013, the Company recorded a net charge of $796, representing the Company’s best estimate that ultimately may be paid related to the 2013 assessment referenced above.  This charge remains accrued and outstanding as of September 30, 2014.
 
The charges taken by the Company in 2010 and in the fourth quarter of 2013 assume a successful recovery of the VAT incorrectly paid, as well as reductions in interest and penalties from anticipated future amnesty programs or settlements.  On a similar basis, if all other potentially impacted jurisdictions were to initiate audits and issue assessments, the remaining exposure, net of refunds, could be from $0 to $7,800 with one jurisdiction representing approximately 84 percent of this additional exposure, assuming the continued availability of future amnesty programs or settlements to reduce the interest and penalties.  If there are future assessments but no such future amnesty programs or settlements, the potential exposure could be higher.
 
The Company is party to other litigation which management currently believes will not have a material adverse effect on the Company’s results of operations, cash flows or financial condition.

 
21

 Table of Contents

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	
 
Executive Summary
 
Quaker Chemical Corporation is a leading global provider of process fluids, chemical specialties, and technical expertise to a wide range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and others.  For nearly 100 years, Quaker has helped customers around the world achieve production efficiency, improve product quality, and lower costs through a combination of innovative technology, process knowledge, and customized services.  Headquartered in Conshohocken, Pennsylvania USA, Quaker serves businesses worldwide with a network of dedicated and experienced professionals whose mission is to make a difference.
 
The Company’s third quarter of 2014 was one of its strongest quarters in recent years in terms of sales volume, operating performance, net results and liquidity.  Net sales grew 8% from the third quarter of 2013, primarily on increased product volumes, including its recent acquisition. The Company’s gross profit followed its increased sales volumes from the third quarter of 2013, as its gross margin percentage remained relatively consistent at 35.4% in the third quarter of 2014 compared to 35.9% in the third quarter of 2013.  Selling, general and administrative expenses (“SG&A”) increased $2.6 million from the third quarter of 2013 on higher labor related costs, acquisition related costs and a U.S. customer bankruptcy, net of the Company’s prior year cost streamlining initiatives and the effects of foreign exchange.  These contributions to the Company’s operating performance for the third quarter of 2014 were supplemented by an increase in other income and a lower tax rate compared to the third quarter of 2013, which are further discussed in the Company’s Consolidated Operations Review section below.
 
From a business perspective, the Company’s third quarter of 2014 operating performance was highlighted by increased volumes over all of its regions, with the exception of South America, where we continue to experience negative impacts from low production and foreign exchange.  Related to the remaining regions growth, North America continues to experience higher volume levels and a slight increase in gross margin on an improving domestic economy.  Similarly, both EMEA and Asia/Pacific experienced quarters with higher volume levels on continued market share gains.  Overall, each of the three regions’ improved sales were partially offset by higher manufacturing costs, direct SG&A costs and other labor costs related to increased volume levels.
 
The net result was earnings per diluted share of $1.18 for the third quarter of 2014 compared to earnings per diluted share of $0.95 for the third quarter of 2013, with non-GAAP earnings per diluted share of $1.19 for the third quarter of 2014 increasing 31% from $0.91 for the third quarter of 2013.  In addition, the Company’s third quarter of 2014 adjusted EBITDA increased 16% to $26.5 million from $22.8 million in the third quarter of 2013, consistent with the operating income trends discussed above.  See the Non-GAAP Measures section in this Item, below.
 
These strong quarterly earnings and an overall improvement in the Company’s working capital management drove net operating cash flows to reach approximately $29.8 million for the third quarter of 2014 compared to $24.5 million in the third quarter of 2013, which increased the Company’s year-to-date net operating cash flows to $38.0 million compared to $51.9 million for the first nine months of 2013.
 
The Company is very pleased with its overall performance for the third quarter of 2014.  Specifically, the Company continues to advance its volume levels with double-digit growth in each of its three largest regions, which more than offset a decline in its smallest region, South America.   These improved volumes have been achieved despite an overall slowing global economy.  The Company’s above-market revenue growth of 8% and strong earnings growth are a testament to the strength of its people, business model and competitive positioning.   As it relates to the Company’s liquidity, its cash position continued to exceed its debt at September 30, 2014 and its consolidated leverage ratio continued to be less than one times EBITDA; despite the added borrowings to purchase ECLI, which highlights the Company’s liquidity as its strength.  Going forward, the Company continues to see an uncertain environment in many countries throughout the world.  However, the Company believes its track record of increasing market share and leveraging recent acquisitions will continue, which should help offset these potential market issues.  Overall, the Company remains confident in its future and expects 2014 to be another good year for Quaker.
 
Liquidity and Capital Resources
 
Quaker’s cash and cash equivalents decreased to $64.2 million at September 30, 2014 from $68.5 million at December 31, 2013.  The $4.3 million decrease was the net result of $38.0 million of cash provided by operating activities, $58.9 million of cash used in investing activities, $19.6 million of cash provided by financing activities and $3.0 million of a decrease due to foreign exchange.
 
Net cash flows provided by operating activities were $38.0 million in the first nine months of 2014 compared to $51.9 million provided by operating activities in the first nine months of 2013.  The Company’s $13.9 million lower operating cash flow was primarily due to higher working capital investment during the first nine months of 2014 compared to the first nine months of 2013.  Specifically, the Company had higher cash outflows from accounts receivable during the first nine months of 2014, which was primarily due to increased sales at the end of the third quarter of 2014 and a delay in the timing of cash receipts in certain regions.  Also, the Company had higher cash outflows from inventory due to re-establishing safety stock levels that were low at year-end 2013

22

 Table of Contents
 
and less cash inflows from accounts payable and accrued liabilities primarily related to higher annual incentive compensation payouts on the Company’s improved performance in the prior year.   In addition, the Company’s operating cash flow comparison was also affected by a $2.0 million dividend distribution received in the prior year from its captive insurance equity affiliate.
 
Net cash flows used in investing activities increased from $8.7 million in the first nine months of 2013 to $58.9 million in the first nine months of 2014.   The $50.2 million increase of cash used in investing activities was primarily the result of higher payments for acquisitions and property, plant and equipment.  Related to acquisitions, the Company invested $52.0 million during the first nine months of 2014 to purchase ECLI Products, LLC (“ECLI”) for its North American segment compared to $2.5 million invested in the first nine months of 2013 for a business that primarily related to tin plating and a chemical milling maskants distribution network for the Company’s North American segment.  Related to property, plant and equipment, the Company has had higher investments during the first nine months of 2014 in its information technology development and other related initiatives primarily in its EMEA and North America segments, compared to higher payments during the first nine months of 2013 for the expansion of the Company’s Asia/Pacific facilities.  In addition, the Company had higher cash inflow during the first nine months of 2014 from a change in the Company’s restricted cash, which is dependent upon the timing of claims and payments associated with the subsidiary’s asbestos litigation.
 
Net cash flows provided by financing activities were $19.6 million in the first nine months of 2014 compared to $21.7 million of cash used in financing activities in the first nine months of 2013.  The $41.3 million change in cash provided by financing activities was due to a change from repayments of external debt on the Company’s revolving credit line made during the first nine months of 2013 compared to the current year borrowings on the Company’s revolving credit line.  The current year borrowings were primarily used to fund the increase in the Company’s investing and financing activities, with its recent acquisition of ECLI mentioned above, its $7.6 million purchase of its remaining interest in its Australian affiliate and its $4.7 million acquisition-related earnout payment.
 
The Company’s primary credit line is a $300.0 million syndicated multicurrency credit agreement with Bank of America, N.A. (administrative agent) and certain other major financial institutions, which matures in June 2018.  At the Company’s option, the principal amount available can be increased to $400.0 million if the lenders agree to increase their commitments and the Company satisfies certain conditions.  At September 30, 2014, the Company had $45.0 million of borrowings outstanding under this facility, compared to no borrowings outstanding as of December 31, 2013.  The Company’s access to this credit is largely dependent on its consolidated leverage ratio covenant, which cannot exceed 3.50 to 1.  At September 30, 2014 and December 31, 2013, the consolidated leverage ratio was below 1.0 to 1, and the Company was also in compliance with all of the facility’s other covenants.
 
At September 30, 2014, the Company’s gross liability for uncertain tax positions, including interest and penalties, was $15.2 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability. However, should the entire liability be paid, the amount of the payment may be reduced by up to $10.4 million as a result of offsetting benefits in other tax jurisdictions.
 
The Company believes it is capable of supporting its operating requirements, including pension plan contributions, payments of dividends to shareholders, possible acquisitions and other business opportunities, capital expenditures and possible resolution of contingencies, through internally generated funds supplemented with debt or equity as needed.
 
Critical Accounting Policies
 
The Company’s critical accounting policies set forth in its Annual Report on Form 10-K for the year ended December 31, 2013 remain materially consistent.  However, the Company completed its annual goodwill and other intangible impairment assessment during the third quarter of 2014.  Based on such, the following is an update to the Company’s related critical accounting policy:
 
Goodwill and other intangible assets - The Company records goodwill and intangible assets at fair value as of the acquisition date and amortizes definite-lived intangible assets on a straight-line basis over the useful lives of the intangible assets based on third-party valuations of the assets.  Goodwill and intangible assets, which have indefinite lives, are not amortized and are required to be assessed at least annually for impairment. The Company compares the assets’ fair value to their carrying value, primarily based on future discounted cash flows, in order to determine if an impairment charge is warranted. The estimates of future cash flows involve considerable management judgment and are based upon assumptions about expected future operating performance. Assumptions used in these forecasts are consistent with internal planning, but the actual cash flows could differ from management’s estimates due to changes in business conditions, operating performance, and economic conditions. The Company’s assumption of weighted average cost of capital (“WACC”) and estimated future net operating profit after tax (“NOPAT”) are particularly important in determining estimated future cash flows.
 
  The Company completed its annual impairment assessment as of the end of the third quarter of 2014, and no impairment charge was warranted.  Furthermore, the estimated fair value of each of the Company’s reporting units substantially exceeded its carrying value, with none of the Company’s reporting units at risk for failing step one of the goodwill impairment test.  The Company’s consolidated goodwill and indefinite-lived intangible assets at September 30, 2014 and December 31, 2013 were $71.2 million and $59.3 million, respectively. The Company currently uses a WACC of 12% and, at September 30, 2014, this assumption would have had to increase by more than 8.9 percentage points before any of the Company’s reporting units would fail step one of the impairment

23

 Table of Contents
 
analysis.  Furthermore, at September 30, 2014, the Company’s estimate of future NOPAT would have had to decrease by more than 38.2% before any of the Company’s reporting units would be considered potentially impaired.
 
Non-GAAP Measures
 
Included in this Form 10-Q filing are non-GAAP financial measures of non-GAAP earnings per diluted share and adjusted EBITDA.  The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader’s understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP measures exclude items that are not considered core to the Company’s operations.  These non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
 
The following is a reconciliation between the non-GAAP (unaudited) financial measure of non-GAAP earnings per diluted share to its most directly comparable GAAP (unaudited) financial measure:

 	 	Three Months Ended	 	 	Nine Months Ended	
 	 	September 30,	 	 	September 30,	
 	 	 	2014 	 	 	 	2013 	 	 	 	2014 	 	 	 	2013 	
GAAP earnings per diluted share attributable to Quaker Chemical Corporation	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Common Shareholders	 	$	1.18 	 	 	$	0.95 	 	 	$	3.31 	 	 	$	3.21 	
UK pension plan amendment per diluted share	 	 	— 	 	 	 	— 	 	 	 	0.05 	 	 	 	— 	
U.S. customer bankruptcy per diluted share	 	 	0.02 	 	 	 	— 	 	 	 	0.02 	 	 	 	— 	
Mineral oil excise tax refund per diluted share	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(0.14)	
Change in acquisition-related earnout liability per diluted share	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	0.03 	
Cost streamlining initiatives per diluted share	 	 	— 	 	 	 	0.05 	 	 	 	 0.02 	 	 	 	0.07 	
Currency conversion impacts of the Venezuelan Bolivar Fuerte per diluted share	 	 	— 	 	 	 	— 	 	 	 	 0.02 	 	 	 	0.03 	
Equity income in a captive insurance company per diluted share	 	 	(0.01)	 	 	 	(0.09)	 	 	 	(0.16)	 	 	 	(0.33)	
Non-GAAP earnings per diluted share	 	$	1.19 	 	 	$	0.91 	 	 	$	3.26 	 	 	$	2.87 	
 
The following is a reconciliation between the non-GAAP (unaudited) financial measure of adjusted EBITDA to its most directly comparable GAAP (unaudited) financial measure:

 	 	Three Months Ended	 	 	Nine Months Ended	
 	 	September 30,	 	 	September 30,	
 	 	 	2014 	 	 	 	2013 	 	 	 	2014 	 	 	 	2013 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income attributable to Quaker Chemical Corporation	 	$	15,696 	 	 	$	12,551 	 	 	$	43,853 	 	 	$	42,253 	
Depreciation and amortization	 	 	4,196 	 	 	 	3,952 	 	 	 	11,908 	 	 	 	11,840 	
Interest expense	 	 	641 	 	 	 	717 	 	 	 	1,747 	 	 	 	2,223 	
Taxes on income before equity in net income of associated companies	 	 	5,724 	 	 	 	5,972 	 	 	 	18,808 	 	 	 	16,933 	
UK pension plan amendment	 	 	— 	 	 	 	— 	 	 	 	902 	 	 	 	— 	
U.S customer bankruptcy	 	 	310 	 	 	 	— 	 	 	 	310 	 	 	 	— 	
Mineral oil excise tax refund	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	(2,540)	
Change in acquisition-related earnout liability	 	 	— 	 	 	 	— 	 	 	 	— 	 	 	 	675 	
Cost streamlining initiatives	 	 	— 	 	 	 	875 	 	 	 	348 	 	 	 	1,277 	
Currency conversion impacts of the Venezuelan Bolivar Fuerte	 	 	— 	 	 	 	— 	 	 	 	321 	 	 	 	357 	
Equity income in a captive insurance company	 	 	(72)	 	 	 	(1,247)	 	 	 	(2,142)	 	 	 	(4,378)	
Adjusted EBITDA	 	$	26,495 	 	 	$	22,820 	 	 	$	76,055 	 	 	$	68,640 	

 
24

 Table of Contents
 
Out-of-Period Adjustment
 
During 2012, the Company reassessed its ability to significantly influence the operating and financial policies of its captive insurance equity affiliate, Primex.  Based on its ownership percentage and other factors, the Company determined that, during 2012, the Company obtained the ability to significantly influence Primex and, as a result, changed its method of accounting from the cost to equity method.   During the first quarter of 2013, the Company identified errors in Primex’s estimated 2012 financial statements, which primarily related to a reinsurance contract held by Primex.  The identified errors resulted in a cumulative $1.0 million understatement of the Company’s equity in net income from associated companies for the year ended December 31, 2012.  The Company corrected the errors related to Primex in the first quarter of 2013, which had the net effect of increasing equity in net income from associated companies by $1.0 million for the three months ended March 31, 2013.  The Company did not believe this adjustment was material to its consolidated financial statements for the years ended December 31, 2012 or December 31, 2013 and, therefore, did not restate any prior period amounts.  See Note 3 of Notes to Condensed Consolidated Financial Statements.
 
Consolidated Operations Review
 
Comparison of the Third Quarter of 2014 with the Third Quarter of 2013
 
Net sales for the third quarter of 2014 of $198.9 million increased approximately 8% from net sales of $184.1 million for the third quarter of 2013.  Base product volumes increased net sales by 8%, partially offset by decreases due to changes in price and product mix of 2% and a slight decrease of approximately $0.5 million, or less than 1%, due to foreign currency exchange rate translation.  Also, included in the Company’s net sales growth for the third quarter of 2014 was approximately 2% of additional sales from its acquisition of ECLI.
 
Gross profit increased approximately $4.3 million, or approximately 7%, from the third quarter of 2013 on the increase from sales volumes, noted above, on relatively consistent gross margins of 35.4% and 35.9% for the third quarter of 2014 and the third quarter of 2013, respectively.
 
SG&A increased approximately $2.6 million from the third quarter of 2013.  The increase in SG&A was driven by higher labor-related costs primarily on increased sales and merit inflation, incentive compensation increases, acquisition-related costs and a U.S. customer bankruptcy of approximately $0.3 million, or $0.02 per diluted share, partially offset by the effects of foreign exchange and the Company’s prior year cost streamlining initiatives in its EMEA region of approximately $0.7 million, or $0.04 per diluted share.
 
The Company had other income of $0.9 million in the third quarter of 2014 compared to other expense of $0.7 million in the third quarter of 2013.  The change to other income for the third quarter of 2014 was the result of foreign exchange gains and receipts of annual government grants in one of the Company’s regions.  Comparatively, the third quarter of 2013 had significant foreign exchange losses, a charge of $0.2 million, or $0.01 per diluted share, related to the cost streamlining initiatives, noted above, and minimal related government grants, as the majority of such grants were recognized in different quarters of the prior year.
 
Interest expense was slightly lower in the third quarter of 2014 compared to the third quarter of 2013.  The Company incurred additional interest expense in the current quarter on higher average borrowings due to its recent acquisition activity, but this was more than offset by prior year interest expense from the accretion of an acquisition-related earnout liability that was settled in 2014.
 
Interest income was higher in the third quarter of 2014 compared to the third quarter of 2013, primarily due to interest received on certain tax-related credits and an increase in the level of the Company’s invested cash in regions with higher returns.
 
The Company’s effective tax rates for the third quarters of 2014 and 2013 were 26.7% and 33.8%, respectively.  The Company has historically recognized a third quarter tax rate that is lower than its annual effective tax rate.  However, in the prior year, the Company’s effective tax rate was impacted by an entity in its Asia/Pacific region, where it was recording tax expense at its statutory tax rate of 25% while it awaited recertification of a concessionary tax rate.
 
Equity in net income of associated companies (“equity income”) decreased $1.2 million in the third quarter of 2014 compared to the third quarter of 2013.  The primary component of the Company’s equity income is its interest in a captive insurance company.  Earnings attributable to this equity interest were $0.1 million, or $0.01 per diluted share, for the third quarter of 2014 compared to $1.2 million, or $0.09 per diluted share, for the third quarter of 2013.
 
The $0.3 million decrease in net income attributable to noncontrolling interest in the third quarter of 2014 compared to the third quarter of 2013 was primarily due to the Company’s second quarter of 2014 acquisition of the noncontrolling interest in its Australian affiliate.
 
      Overall, the Company realized a minimal impact to its net income from its current quarter acquisitions, as their respective operational results were offset by acquisition-related costs and initial adjustments related to fair value accounting.
 
Changes in foreign exchange rates positively impacted the third quarter of 2014 net income by approximately $0.1 million, or $0.01 per diluted share.

25

 Table of Contents
 
Comparison of the First Nine Months of 2014 with the First Nine Months of 2013
 
Net sales for the first nine months of 2014 of $571.8 million increased 5% from $545.1 million for the first nine months of 2013.  Base product volumes increased net sales by 5%, partially offset by decreases due to changes in price and product mix of less than 1% and the impact of approximately $3.7 million, or less than 1%, due to foreign currency exchange rate translation.  Also, included in the Company’s net sales growth for the first nine months of 2014 was approximately 1% of additional sales from its acquisition of ECLI.
 
Gross profit increased approximately $7.7 million, or approximately 4%, from the first nine months of 2013, which was primarily driven by the increase in sales volumes, noted above, on relatively consistent gross margins of 35.6% and 35.9% for the first nine months of 2014 and the first nine months of 2013, respectively.  Slightly decreasing the first nine months of 2014 gross profit and gross margin was approximately $0.3 million, or $0.02 per diluted share, of expenses to finalize the manufacturing cost streamlining initiatives that began in the prior year in our EMEA segment.
 
SG&A increased approximately $2.9 million from the first nine months of 2013.  The increase in SG&A was driven by higher labor-related costs primarily on increased sales and merit inflation, acquisition-related costs, the U.S. customer bankruptcy mentioned above and, also, $0.9 million, or $0.05 per diluted share, of additional costs related to an amendment to the Company’s pension plan in the United Kingdom (“UK”).  These increases to the first nine months of 2014 SG&A were partially offset by lower incentive compensation costs, decreases in foreign currency exchange rate translation, and additional costs in the prior year of $1.1 million, or $0.06 per diluted share, related to the EMEA and South America cost streamlining initiatives.
 
The $1.4 million decrease in other income in the first nine months of 2014 from other income in the first nine months of 2013 was primarily caused by the Company’s prior year receipt of a mineral oil excise tax refund of $2.5 million, or $0.14 per diluted share, net of the prior year expense related to a change in an acquisition-related earnout liability of $0.7 million, or $0.03 per diluted share, and the charge related to the third quarter of 2013 cost streamlining initiatives, noted above.
 
Interest expense was lower in the first nine months of 2014 compared to the first nine months of 2013, primarily due to decreases in average borrowings, lower average interest rates and the prior year interest accretion on an acquisition-related earnout liability, discussed above.
 
Interest income was higher in the first nine months of 2014 compared to the first nine months of 2013, primarily due to interest received on several tax-related credits and an increase in the average level of the Company’s cash on hand in the current year.
 
The Company’s effective tax rates for the first nine months of 2014 and 2013 were relatively consistent at 30.5% and 30.0%, respectively.  Both effective tax rates reflect decreases in reserves for uncertain tax positions due to the expiration of applicable statutes of limitations for certain tax years of approximately $0.06 and $0.13 per diluted share for the nine months ended 2014 and nine months ended 2013, respectively.  The earnings per diluted share impact related to changes in uncertain tax positions was lower in the current year, however, this impact was offset by recording tax expense at the statutory tax rate of one of the Company’s Asia/Pacific entities in the prior year, noted above.  The Company still estimates that its full year 2014 effective tax rate will approximate 31%. The Company has experienced and expects to further experience volatility in its effective tax rates due to the varying timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, among other factors.
 
The decrease in the Company’s equity income of $2.2 million from the first nine months of 2013 to the first nine months of 2014 was primarily caused by lower earnings related to the Company’s equity interest in a captive insurance company.  Earnings attributable to this equity interest were $2.1 million, or $0.16 per diluted share, in the first nine months of 2014 compared to $4.4 million, or $0.33 per diluted share, in the first nine months of 2013, including a $1.0 million out-of-period adjustment.  See the Out-of-Period Adjustment section in this item, above.   In addition, the Company’s equity income for both the first nine months of 2014 and the first nine months of 2013 include currency charges related to the conversion of the Venezuelan Bolivar Fuerte to the U.S. Dollar of $0.3 million, or $0.02 per diluted share, and $0.4 million, or $0.03 per diluted share, respectively.
 
The primary component of the $0.4 million decrease in net income attributable to noncontrolling interest from the first nine months of 2013 was the Company’s acquisition of the noncontrolling interest in its Australian affiliate, discussed above.
 
Changes in foreign exchange rates negatively impacted the first nine months of 2014 net income by approximately $0.7 million, or $0.05 per diluted share.

26

 Table of Contents
 
Reportable Operating Segment Review
 
The Company offers its industrial process fluids, chemical specialties and technical expertise to a wide range of industries in a global product portfolio throughout its four segments:  (i) North America, (ii) Europe, Middle East and Africa (“EMEA”), (iii) Asia/Pacific and (iv) South America.
 
Comparison of the Third Quarter of 2014 with the Third Quarter of 2013
 
North America
 
North America represented approximately 44% of the Company’s consolidated net sales in the third quarter of 2014, which increased approximately $8.3 million, or 10%, from the third quarter of 2013.  The increase in net sales was primarily attributable to higher base product volumes, including acquisitions, of 13%, partially offset by a 3% decrease due to price and product mix.  This reportable segment’s operating earnings, excluding indirect expenses, increased approximately $2.6 million, or 17%, from the third quarter of 2013.  The third quarter of 2014 increase was mainly driven by higher gross profit on the increases to net sales, noted above, and a slight margin improvement on a change in product mix, partially offset by higher labor-related costs on improved segment performance and general year-over-year merit increases.
 
EMEA
 
EMEA represented approximately 25% of the Company’s consolidated net sales in the third quarter of 2014, which increased approximately $4.9 million, or 11%, from the third quarter of 2013.  The increase in net sales was primarily attributable to higher base product volumes of 14%, partially offset by a 3% decrease due to price and product mix.  Impacts due to foreign currency exchange rate translations were consistent between the third quarter of 2014 and the third quarter of 2013.   This reportable segment’s operating earnings, excluding indirect expenses, increased approximately $1.8 million, or 27%, from the third quarter of 2013.  The third quarter of 2014 increase was mainly driven by higher gross profit on the increases to net sales, noted above,  and favorable impacts due to the prior year cost streamlining initiatives taken in the region, partially offset by higher labor-related costs on improved segment performance and general year-over-year merit increases.
 
Asia/Pacific
 
Asia/Pacific represented approximately 25% of the Company’s consolidated net sales in the third quarter of 2014, which increased approximately $5.5 million, or 13%, from the third quarter of 2013.  The increase in net sales was primarily due to higher base product volumes of 14% and an increase due to foreign currency exchange rate translation of 1%, partially offset by a decrease due to price and product mix of 2%.  The foreign currency exchange rate translation impact was primarily due to an improvement in the Indian Rupee to U.S. Dollar exchange rate, which averaged 0.0165 in the third quarter of 2014 compared to 0.0161 in the third quarter of 2013.  This reportable segment’s operating earnings, excluding indirect expenses, increased approximately $0.7 million, or 6%, from the third quarter of 2013.  The third quarter of 2014 increase was mainly driven by higher gross profit on the increases to net sales, noted above, net of slightly lower margin percentage due to a change in price and product mix and higher labor-related costs on  improved segment performance and general year-over-year merit increases.
 
South America
 
South America represented approximately 6% of the Company’s consolidated net sales in the third quarter of 2014, which decreased approximately $3.9 million, or 25%, from the third quarter of 2013.  The decrease in net sales was generally attributable to lower product volumes of 28% and a decrease from foreign currency exchange rate translation of 4%, partially offset by an increase in price and product mix of 7%.  The foreign currency exchange rate translation impact was primarily due to a decrease in the Argentinian Peso to U.S. Dollar exchange rate, which averaged 0.1206 in the third quarter of 2014 compared to 0.1793 in the third quarter of 2013, respectively.  This reportable segment’s operating earnings, excluding indirect expenses, decreased approximately $1.7 million, or 66%, from the third quarter of 2013.  The third quarter of 2014 decrease was mainly driven by lower gross profit on the decreases to net sales, noted above, and a gross margin decline on a change in price and product mix, partially offset by the positive impacts from the cost streamlining initiatives taken in this segment during 2013 and lower labor-related costs on decreased segment performance.
 
Comparison of the First Nine Months of 2014 with the First Nine Months of 2013
 
North America
 
North America represented approximately 43% of the Company’s consolidated net sales in the first nine months of 2014, which increased approximately $16.0 million, or 7%, from the first nine months of 2013.  The increase in net sales was generally attributable to higher base product volumes, including acquisitions, of 9%, partially offset by a 2% decrease related to price and product mix.  This reportable segment’s operating earnings, excluding indirect expenses, increased approximately $5.1 million, or 11%, from the first nine months of 2013.  The increase during the first nine months of 2014 was mainly driven by higher gross profit on the increases to net sales, noted above, and a slight margin improvement on a change in price and product mix, partially offset by higher labor-related costs on improved segment performance and general year-over-year merit increases.

27

 Table of Contents
 
EMEA
 
EMEA represented approximately 26% of the Company’s consolidated net sales in the first nine months of 2014, which increased approximately $8.4 million, or 6%, from the first nine months of 2013.  The increase in net sales was generally attributable to higher base product volumes of 5% and positive foreign currency exchange rate translation of 3%, partially offset by decreases related to price and product mix of 2%.  The foreign currency exchange rate translation impact was primarily due to an increase in the E.U. Euro to U.S. Dollar exchange rate, which averaged 1.36 in the first nine months of 2014 compared to an average of 1.32 in the first nine months of 2013.  This reportable segment’s operating earnings, excluding indirect expenses, increased approximately $2.5 million, or 11%, from the first nine months of 2013.  The increase during the first nine months of 2014 was mainly driven by higher gross profit on the increases to net sales, noted above, partially offset by additional costs in the current year to finalize the prior year manufacturing cost streamlining initiatives and higher labor-related costs on improved segment performance and general year-over-year merit increases.
 
Asia/Pacific
 
Asia/Pacific represented approximately 24% of the Company’s consolidated net sales in the first nine months of 2014, which increased approximately $12.1 million, or 10%, from the first nine months of 2013.  The increase in net sales was primarily due to higher product volumes of 10% and an increase due to price and product mix of 1%, partially offset by a decrease from foreign currency exchange rate translation of 1%.  The foreign currency exchange rate translation impact was primarily due to a decrease in the Indian Rupee and Australian Dollar to U.S. Dollar exchange rates, which averaged 0.0165 and 0.9181 in the first nine months of 2014 compared to 0.0175 and 0.9816 in the first nine months of 2013, respectively.  This reportable segment’s operating earnings, excluding indirect expenses, increased approximately $0.4 million, or 1%, from the first nine months of 2013.  The increase in the first nine months of 2014 was mainly driven by higher gross profit on the increases to net sales, noted above, partially offset by lower gross margins due to a change in price and product mix and, also, higher labor-related costs on improved segment performance and general year-over-year merit increases.
 
South America
 
South America represented approximately 7% of the Company’s consolidated net sales in the first nine months of 2014, which decreased approximately $9.8 million, or 20%, from the first nine months of 2013.  The decrease in net sales was generally attributable to lower product volumes of 15% and a decrease from foreign currency exchange rate translation of 11%, partially offset by an increase in price and product mix of 6%.  The foreign currency exchange rate translation impact was primarily due to a decrease in the Brazilian Real and Argentinian Peso to U.S. Dollar exchange rates, which averaged 0.437 and 0.126 in the first nine months of 2014 compared to 0.474 and 0.190 in the first nine months of 2013, respectively.  This reportable segment’s operating earnings, excluding indirect expenses, decreased approximately $4.5 million, or 58%, from the first nine months of 2013.  The first nine months of 2014 decrease was mainly driven by lower gross profit on the decreases to net sales, noted above, and a gross margin decline on a change in price and product mix, partially offset by the positive impacts from the cost streamlining initiatives taken in this segment during 2013 and the impacts on SG&A related to lower segment performance.
 
Factors That May Affect Our Future Results
 
(Cautionary Statements Under the Private Securities Litigation Reform Act of 1995)
 
Certain information included in this Report and other materials filed or to be filed by Quaker with the SEC (as well as information included in oral statements or other written statements made or to be made by us) contain or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on our current expectations about future events. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance and business, including:
 
·  	statements relating to our business strategy;	

·  	our current and future results and plans; and	

·  	statements that include the words “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan” or similar expressions.	
 
Such statements include information relating, among other things, to current and future business activities, operational matters, capital spending, and financing sources. From time to time, forward-looking statements are also included in Quaker’s other periodic reports on Forms 10-K, 10-Q and 8-K, as well as in press releases and other materials released to, or statements made to, the public.
 
 Any or all of the forward-looking statements in this Report and in any other public statements we make may turn out to be wrong. This can occur as a result of inaccurate assumptions or as a consequence of known or unknown risks and uncertainties. Many factors discussed in this Report will be important in determining our future performance. Consequently, actual results may differ materially from those that might be anticipated from our forward-looking statements.

28

 Table of Contents
 
We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in Quaker’s subsequent reports on Forms 10-K, 10-Q and 8-K should be consulted. These forward-looking statements are subject to risks, uncertainties and assumptions about us and our operations that are subject to change based on various important factors, some of which are beyond our control. A major risk is that the Company’s demand is largely derived from the demand for its customers’ products, which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, worldwide economic and political conditions, foreign currency fluctuations, terrorist attacks and other acts of violence. Furthermore, the Company is subject to the same business cycles as those experienced by steel, automobile, aircraft, appliance, and durable goods manufacturers. These risks, uncertainties and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. Other factors beyond those discussed could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

29

 Table of Contents

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	
 
We have evaluated the information required under this Item that was disclosed in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2013, and we believe there has been no material change to that information.

 
30

 Table of Contents

Item 4.	Controls and Procedures.	
 
Evaluation of disclosure controls and procedures. As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, including our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report.  Based on that evaluation, our principal executive officer and our principal financial officer have concluded that as of the end of the period covered by this report our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were effective.
 
Changes in internal control over financial reporting. As required by Rule 13a-15(d) under the Exchange Act, our management, including our principal executive officer and principal financial officer, has evaluated our internal control over financial reporting to determine whether any changes to our internal control over financial reporting occurred during the quarter ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  Based on that evaluation, no such changes to our internal control over financial reporting occurred during the quarter ended September 30, 2014.

 
31

 Table of Contents

PART II. 
OTHER INFORMATION
 
Items 1A, 3, 4 and 5 of Part II are inapplicable and have been omitted.
 
Item 1.  Legal Proceedings.
 
Incorporated by reference is the information in Note 15 of the Notes to the Condensed Consolidated Financial Statements in Part I, Item 1 of this report.
 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
 
The following table sets forth information concerning shares of the Company’s common stock acquired by the Company during the period covered by this report.

 	 	 	 	 	 	 	(c)	 	(d)	
 	 	 	 	 	 	 	Total Number of	 	Maximum	
 	 	 	 	 	 	 	Shares Purchased as	 	Number of Shares that	
 	 	(a)	 	 	(b)	 	Part of	 	May Yet	
 	 	Total Number	 	 	Average	 	Publicly Announced	 	Be Purchased Under the	
 	 	of Shares	 	 	Price Paid	 	Plans	 	Plans or	
Period	 	Purchased (1)	 	 	Per Share (2)	 	or Programs (3)	 	Programs (3)	
July 1 - July 31	 	229 	 	$	77.06 	 	— 	 	252,600 	
August 1 - August 31	 	297 	 	$	71.04 	 	— 	 	252,600 	
September 1 - September 30	 	2,816 	 	$	75.26 	 	— 	 	252,600 	
 	 	 	 	 	 	 	 	 	 	
Total	 	3,342 	 	$	75.01 	 	— 	 	252,600 	
 
(1)  	All of the 3,342 shares acquired by the Company during the period covered by this report were acquired from employees upon their surrender of previously owned shares in payment of the exercise price of employee stock options exercised, for the payment of taxes upon exercise of employee stock options or for the vesting of restricted stock.	
 
(2)  	The price per share, in each case, represented the closing price of the Company’s common stock on the date of exercise or vesting, as specified by the plan pursuant to which the applicable option or restricted stock was granted.	
 
(3)  	On February 15, 1995, the Board of Directors of the Company authorized a share repurchase program authorizing the repurchase of up to 500,000 shares of Quaker common stock, and, on January 26, 2005, the Board authorized the repurchase of up to an additional 225,000 shares.  Under the 1995 action of the Board, 27,600 shares may yet be purchased.  Under the 2005 action of the Board, none of the shares authorized have been purchased and, accordingly, all of those shares may yet be purchased.  Neither of the share repurchase authorizations has an expiration date.	

 
32

 Table of Contents

Item 6.	Exhibits.	
 
(a) Exhibits	 	 	
 	 	 	 	 	
31.1	 	–	 	Certification of Chief Executive Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934	
31.2	 	–	 	Certification of Chief Financial Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934	
32.1	 	–	 	Certification of Michael F. Barry Pursuant to 18 U.S.C. Section 1350	
32.2	 	–	 	Certification of Margaret M. Loebl Pursuant to 18 U.S.C. Section 1350	
101.INS	 	–	 	XBRL Instance Document	
101.SCH	 	–	 	XBRL Extension Schema Document	
101.CAL	 	–	 	XBRL Calculation Linkbase Document	
101.DEF	 	–	 	XBRL Definition Linkbase Document	
101.LAB	 	–	 	XBRL Label Linkbase Document	
101.PRE	 	–	 	XBRL Presentation Linkbase Document	

*********
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 	 	 	 	QUAKER CHEMICAL CORPORATION
                        (Registrant)	
 	 	 	
 	 	 	 	/s/ Margaret M. Loebl	
Date: October 28, 2014	 	 	 	Margaret M. Loebl, Vice President, Chief Financial Officer and Treasurer
(Officer duly authorized on behalf of, and Principal Financial Officer of, the Registrant)	

33

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE COMPANY PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
 
I, Michael F. Barry, certify that:
 
1.	I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 	
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made  known to us by others within those entities, particularly during the period in which this report is being prepared;

 	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 28, 2014

 	 	/s/ Michael F. Barry	
 	 	Michael F. Barry	
 	 	Chief Executive Officer	

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE COMPANY PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
 
I, Margaret M. Loebl, certify that:
 
1.	I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 	
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 28, 2014

 	 	/s/ Margaret M. Loebl	
 	 	Margaret M. Loebl	
 	 	Chief Financial Officer	

EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended September 30, 2014 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 	 	 	
Dated: October 28, 2014	 	/s/ Michael F. Barry	
 	 	Michael F. Barry	
 	 	Chief Executive Officer of Quaker Chemical Corporation	

EXHIBIT 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended September 30, 2014 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 	 	 	
Dated: October 28, 2014	 	/s/ Margaret M. Loebl	
 	 	Margaret M. Loebl	
 	 	Chief Financial Officer of Quaker Chemical Corporation